<SEC-DOCUMENT>0000930413-21-001845.txt : 20211105
<SEC-HEADER>0000930413-21-001845.hdr.sgml : 20211105
<ACCEPTANCE-DATETIME>20211105161645
ACCESSION NUMBER:		0000930413-21-001845
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20211103
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211105
DATE AS OF CHANGE:		20211105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COLGATE PALMOLIVE CO
		CENTRAL INDEX KEY:			0000021665
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				131815595
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00644
		FILM NUMBER:		211384731

	BUSINESS ADDRESS:	
		STREET 1:		300 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		2123102000

	MAIL ADDRESS:	
		STREET 1:		300 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c102503_8k-ixbrl.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Nov 05 17:50:38 UTC 2021 -->
<html xmlns:cl="http://www.colgate.com/20211105" xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace"><head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><b>UNITED STATES</b></p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><span style="font-variant: small-caps"><b>WASHINGTON,
DC</b></span><b> 20549</b></p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>
</div><!-- Field: Rule-Page --><div style="text-align: CENTER;"><div style="font-size: 1pt; border-top: Black 1px solid; width: 20%; margin-left: auto; margin-right: auto;">&#160;</div></div><!-- Field: /Rule-Page --><div>
</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">8-K</ix:nonNumeric></b></p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><b>CURRENT REPORT</b></p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><b>Pursuant to Section
13 or 15(d) of the</b></p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><b>Securities Exchange
Act of 1934</b></p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Date of Report (Date
of earliest event reported) November 5, 2021 (<ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate">November 3, 2021</ix:nonNumeric>)</p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b>COLGATE-PALMOLIVE
COMPANY</b></ix:nonNumeric></p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt">(Exact name of registrant
as specified in its charter)</p><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top"> <td style="width: 30%; text-decoration: underline; text-indent: 0pt; position: relative; top: 0.5pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="font-size: 11pt"><span style="text-decoration:underline">Delaware</span></span></ix:nonNumeric></td> <td style="width: 30%; text-decoration: underline; text-indent: 0pt; position: relative; top: 0.5pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber"><span style="font-size: 11pt"><span style="text-decoration:underline">1-644</span></span></ix:nonNumeric></td> <td style="width: 30%; text-decoration: underline; text-indent: 0pt; position: relative; top: 0.5pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber"><span style="font-size: 11pt"><span style="text-decoration:underline">13-1815595</span></span></ix:nonNumeric></td> <td style="width: 10%">&#160;</td></tr>
<tr style="vertical-align: top"> <td style="text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><span style="font-size: 11pt">(State or Other Jurisdiction</span></td> <td style="text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><span style="font-size: 11pt">(Commission</span></td> <td style="text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><span style="font-size: 11pt">(IRS Employer</span></td> <td>&#160;</td></tr>
<tr style="vertical-align: top"> <td style="text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><span style="font-size: 11pt">of Incorporation)</span></td> <td style="text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><span style="font-size: 11pt">File Number)</span></td> <td style="text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><span style="font-size: 11pt">Identification No.)</span></td> <td>&#160;</td></tr>
</table><div>

</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top"> <td style="width: 15%">&#160;</td> <td style="width: 40%; text-decoration: underline; text-indent: 0pt; position: relative; top: 0.5pt; text-align: center"><span style="font-size: 11pt"><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">300 Park Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span></span></td> <td style="width: 30%; text-decoration: underline; text-indent: 0pt; position: relative; top: 0.5pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode"><span style="font-size: 11pt"><span style="text-decoration:underline">10022</span></span></ix:nonNumeric></td> <td style="width: 15%">&#160;</td></tr>
<tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><span style="font-size: 11pt">(Address of Principal Executive Offices)</span></td> <td style="text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><span style="font-size: 11pt">(Zip Code)</span></td> <td>&#160;</td></tr>
</table><div>
</div><p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 65pt">Registrant&#8217;s
telephone number, including area code (<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">212</ix:nonNumeric>) <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">310-2000</ix:nonNumeric></p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"></p><div>

</div><!-- Field: Rule-Page --><div style="text-align: LEFT;"><div style="font-size: 1pt; border-top: Black 4px solid; width: 85%">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(<i>see</i> General Instruction A.2. below):</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: top"> <td style="width: 4%; text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:WrittenCommunications"><span>&#9744;</span></ix:nonNumeric></td> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
<tr style="vertical-align: top"> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><span style="font: 5pt Times New Roman, Times, Serif">&#160;</span></td> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><span style="font: 5pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top"> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:SolicitingMaterial"><span>&#9744;</span></ix:nonNumeric></td> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
<tr style="vertical-align: top"> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><span style="font: 5pt Times New Roman, Times, Serif">&#160;</span></td> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><span style="font: 5pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top"> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:PreCommencementTenderOffer"><span>&#9744;</span></ix:nonNumeric></td> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
<tr style="vertical-align: top"> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><span style="font: 5pt Times New Roman, Times, Serif">&#160;</span></td> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><span style="font: 5pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top"> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:PreCommencementIssuerTenderOffer"><span>&#9744;</span></ix:nonNumeric></td> <td style="text-indent: 0pt; font-size: 10pt; position: relative; top: 0.5pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table><div>
</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">Securities registered pursuant to Securities
12(b) of the Act:</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr> <td style="vertical-align: top; width: 33%; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><b>Title of each class</b></td> <td style="vertical-align: top; width: 33%; border-top: black 1px solid; border-bottom: black 1px solid; padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><b>Trading Symbol(s)</b></td> <td style="vertical-align: bottom; width: 34%; border-top: black 1px solid; border-bottom: black 1px solid; padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><b>Name of each exchange <br/>
on which registered</b></td></tr>
<tr style="vertical-align: bottom"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c1" name="dei:Security12bTitle">Common Stock, $1.00 par value</ix:nonNumeric></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c1" name="dei:TradingSymbol">CL</ix:nonNumeric></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c1" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle">0.500% Notes due 2026</ix:nonNumeric></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol">CL26</ix:nonNumeric></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c3" name="dei:Security12bTitle">1.375% Notes due 2034</ix:nonNumeric></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c3" name="dei:TradingSymbol">CL34</ix:nonNumeric></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c3" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom"> <td style="border-bottom: black 1px solid; padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c4" name="dei:Security12bTitle">0.875% Notes due 2039</ix:nonNumeric></td> <td style="border-bottom: black 1px solid; padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c4" name="dei:TradingSymbol">CL39</ix:nonNumeric></td> <td style="border-bottom: black 1px solid; padding-top: 0.75pt; padding-right: 0.75pt; text-align: center; text-indent: 0pt; position: relative; top: 0.5pt"><ix:nonNumeric contextRef="c4" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></td></tr>
</table><div>
</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the
Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany"><span>&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span>&#9744;</span></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-bottom: 6pt; border-bottom: Silver 4px solid"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"><tr><td style="text-align: left; width: 100%"></td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 72pt; text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><b>Item 8.01.</b></span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><b>Other Events.</b></span></td></tr>
</table><div>
</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">On November 3, 2021, Colgate-Palmolive Company
(the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Citigroup Global Markets
Limited and Banco Bilbao Vizcaya Argentaria, S.A., as representatives of the several underwriters named therein (the &#8220;Underwriters&#8221;)
in connection with the Company&#8217;s public offering (the &#8220;Offering&#8221;) of &#8364;500,000,000 aggregate principal amount of its 0.300%
Senior Notes due 2029 (the &#8220;Notes&#8221;). Pursuant to the Underwriting Agreement, the Company agreed to sell the Notes to the Underwriters,
and the Underwriters agreed to purchase the Notes for resale to the public. The Offering is expected to close on or about November 10, 2021,
subject to customary closing conditions.</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">The Underwriting Agreement includes customary representations,
warranties and covenants by the Company. It also provides for customary indemnification by each of the Company and the Underwriters against certain liabilities.</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">The Offering was made pursuant to the Company&#8217;s shelf registration
statement on Form S-3 (File No.&#160;333-249768) filed with the Securities and Exchange Commission on October 30, 2020.</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">The Underwriting Agreement is filed as Exhibit 1.1 hereto
and is incorporated herein by reference.</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 72pt; text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><b>Item 9.01.</b></span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
</table><div>
</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 36pt; text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">(d)</span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><i>Exhibits</i>.&#160;&#160;The following exhibits are filed with this document:</span></td></tr>
</table><div>
</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 20%; text-decoration: underline; text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><span style="text-decoration:underline">Exhibit Number</span></span></td>
    <td style="width: 80%; text-decoration: underline; text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><span style="text-decoration:underline">Description</span></span></td></tr>
</table><div>
</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 20%; text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">1.1</span></td>
    <td style="width: 80%; text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><a href="c102503_ex1-1.htm">Underwriting Agreement, dated November 3, 2021, by and among Colgate-Palmolive Company, Citigroup Global Markets Limited and Banco Bilbao Vizcaya Argentaria, S.A.</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">5.1</span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><a href="c102503_ex5-1.htm">Opinion of Hogan Lovells US LLP</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">23.1</span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt"><a href="c102503_ex5-1.htm">Consent of Hogan Lovells US LLP (included in Exhibit 5.1)</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">104</span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)</span></td></tr>
</table><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-bottom: 6pt; border-bottom: Silver 4px solid"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"><tr><td style="text-align: left; width: 100%"></td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><b>SIGNATURE</b></p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p><div>




</div><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt">&#160;</td>
    <td colspan="3" style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><b>COLGATE-PALMOLIVE COMPANY</b></td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt; width: 50%">&#160;</td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt; width: 5%">&#160;</td>
    <td style="padding-bottom: 1px; text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt; width: 35%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt; width: 10%">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">Date:&#160;&#160;November 5, 2021</span></td>
    <td colspan="2" style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">By: &#160;&#160;&#160;&#160;&#160;&#160;/s/ Stanley J. Sutula III</span><div style="font-size: 1pt; border-top: Black 1px solid; margin-left: 20pt">&#160;</div></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt">&#160;</td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">Name:&#160;&#160;</span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">Stanley J. Sutula III</span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt">&#160;</td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">Title:</span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt"><span style="font-size: 12pt">Chief Financial Officer</span></td>
    <td style="text-indent: 0pt; font-size: 12pt; position: relative; top: 0.5pt">&#160;</td></tr>
</table><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-bottom: 6pt; border-bottom: Silver 4px solid"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div><div>
</div><!-- Field: /Page --><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0000021665</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="cl-20211105.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021665</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-11-05</xbrli:startDate>
    <xbrli:endDate>2021-11-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021665</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cl:CommonStock100ParValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-11-05</xbrli:startDate>
    <xbrli:endDate>2021-11-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021665</xbrli:identifier>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+zoEiIZmtp2H7C6qvFYFNeA86aF0ybghYRPDx9gBHG4hrnGiYZKGPUxrjymER5RbLDXbQsGvqMYlkK78awuTh6oFF0/i9MwfwFm0kQaXDPI4HKjtQnZXddYRN/Ji31S6d4X9j5m2q0DLvwkb8LYW4OhBu72OTymXX+Qg3EZBrG1Qae91gPuv5isk78af72UeY57vwyhzIjpai0hCEcTAtahMowdUYAgpg=] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cl:Zero500NotesDue2026Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-11-05</xbrli:startDate>
    <xbrli:endDate>2021-11-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021665</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cl:One375NotesDue2034Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-11-05</xbrli:startDate>
    <xbrli:endDate>2021-11-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021665</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cl:Zero875NotesDue2039Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-11-05</xbrli:startDate>
    <xbrli:endDate>2021-11-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>c102503_ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COLGATE-PALMOLIVE COMPANY</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&euro;500,000,000 0.300% Senior Notes due
2029</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Underwriting Agreement</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 252pt; text-align: right">November 3, 2021</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 252pt; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">Citigroup Global Markets Limited</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">Banco Bilbao Vizcaya Argentaria, S.A.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">As Representatives of the several Underwriters,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt">c/o</TD><TD>Citigroup Global Markets Limited<BR>
Citigroup Centre</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Canada Square, Canary Wharf</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">London E14 5LB</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">United Kingdom</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Banco Bilbao Vizcaya Argentaria, S.A.<BR>
Ciudad BBVA<BR>
C/ Sauceda, 28<BR>
Edificio Asia - 2nd Floor<BR>
28050, Madrid<BR>
Spain</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">Colgate-Palmolive Company, a Delaware corporation
(the &ldquo;Company&rdquo;), proposes to sell to the several underwriters named in Schedule II hereto (the &ldquo;Underwriters&rdquo;),
for whom you (the &ldquo;Representatives&rdquo;) are acting as representatives, the principal amount of its securities identified
in Schedule I hereto (the &ldquo;Securities&rdquo;), to be issued under an indenture (as the same may be amended or restated from
time to time, the &ldquo;Indenture&rdquo;) dated as of November 15, 1992 between the Company and The Bank of New York Mellon (formerly
known as The Bank of New York). The Bank of New York Mellon will act as trustee with respect to the Notes (the &ldquo;Trustee&rdquo;).
To the extent there are no additional Underwriters listed on Schedule II other than you, the term Representatives as used herein
shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the
context requires.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">As used in this underwriting agreement (this
&ldquo;Agreement&rdquo;), the &ldquo;Registration Statement&rdquo; means the registration statement referred to in paragraph 1(a)
hereof, including the exhibits, schedules and financial statements and any prospectus supplement relating to the Securities that
is filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) pursuant to Rule 424(b) under the Securities
Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and the rules and regulations promulgated thereunder (the &ldquo;Securities
Act Regulations&rdquo;) and deemed part of such registration statement pursuant to Rule 430B under the Securities Act, as amended
on each Effective Date, and, in the event any post-effective amendment thereto becomes</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt">effective prior to the Closing Date (as defined
in Section 3 hereof), shall also mean such registration statement as so amended<B>;</B> the &ldquo;Effective Date&rdquo; means
each date and time that the Registration Statement and any post-effective amendment or amendments thereto became or becomes effective;
the &ldquo;Base Prospectus&rdquo; means the base prospectus referred to in paragraph 1(a) hereof contained in the Registration
Statement at the Applicable Time; a &ldquo;Preliminary Prospectus&rdquo; means any preliminary prospectus supplement to the Base
Prospectus referred to in paragraph 1(a) hereof which is used prior to the filing of the Prospectus, together with the Base Prospectus;
the &ldquo;Prospectus&rdquo; means the prospectus supplement relating to the Securities that is first filed pursuant to Rule 424(b)
under the Securities Act (&ldquo;Rule 424(b)&rdquo;) after the Applicable Time, together with the Base Prospectus; and &ldquo;Applicable
Time&rdquo; means the time agreed to by the Company and the Representatives as the time of the pricing of the Notes, which, unless
otherwise agreed, shall be the time immediately after the Company and the Representatives agree on the pricing terms of the Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">Any reference herein to the Registration
Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents
incorporated by reference therein pursuant to Item 12 of Form S-3 which were filed under the Securities Exchange Act of 1934, as
amended (the &ldquo;Exchange Act&rdquo;), and the rules and regulations promulgated thereunder (the &ldquo;Exchange Act Regulations&rdquo;)
on or before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus
or the Prospectus, as the case may be; and any reference herein to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo;
with respect to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to
refer to and include the filing of any document under the Exchange Act after the Effective Date of the Registration Statement or
the issue date of the Base Prospectus, any Preliminary Prospectus or the Prospectus, as the case may be, deemed to be incorporated
therein by reference.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">As used in this Agreement, the &ldquo;Disclosure
Package&rdquo; shall mean as of the Applicable Time, (i) the Base Prospectus, (ii) the Preliminary Prospectus (iii) the final term
sheet prepared and filed pursuant to Section 5(b) hereto constituting an Issuer Free Writing Prospectus (as defined below) and
(iv) any other free writing prospectus, as defined in Rule 405 under the Securities Act (a &ldquo;Free Writing Prospectus&rdquo;)
consented to by the Company and Representative (a &ldquo;Permitted Free Writing Prospectus&rdquo;), that the parties hereto shall
hereafter expressly agree in writing to treat as part of the Disclosure Package.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Representations
and Warranties</U>. The Company represents and warrants to, and agrees with, each Underwriter as set forth below in this Section
1.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company meets the requirements for use of Form S-3 under the Securities Act and has prepared and filed with the Commission an automatic
shelf registration statement, as defined in Rule 405 under the Securities Act (&ldquo;<U>Rule 405</U>&rdquo;) (the file number
of which is set forth in Schedule I hereto) on Form S-3, including a related Base Prospectus, for the registration of the offering
and sale of the Securities under the Securities Act. Such Registration Statement, including any amendments thereto filed prior
to the Applicable Time, became effective upon filing. The Company may have filed with the Commission, as part of an amendment to
the Registration Statement or pursuant to Rule 424(b), preliminary prospectus supplements relating to the Securities,</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">each of which has previously been
furnished to you. The Company will file with the Commission a final prospectus supplement relating to the Securities in accordance
with Rule 424(b) after the Applicable Time. As filed, such final prospectus supplement shall contain all information required by
the Securities Act and the rules thereunder and, except to the extent the Representatives shall agree in writing to a modification,
shall be in all substantive respects in the form furnished to you prior to the Applicable Time or, to the extent not completed
at the Applicable Time, shall contain only such specific additional information and other changes (beyond that contained in the
Base Prospectus and any Preliminary Prospectus) as the Company has advised you, prior to the Applicable Time, will be included
or made therein. The Registration Statement, at the Applicable Time, meets the requirements set forth in Rule 415(a)(1)(x) under
the Securities Act. The initial Effective Date of the Registration Statement was not earlier than the date three years before the
Applicable Time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
each Effective Date, the Registration Statement did, and when the Prospectus is first filed in accordance with Rule 424(b) and
on the Closing Date (as defined herein), the Prospectus (and any supplement thereto) will, comply in all material respects with
the applicable requirements of the Securities Act and the Exchange Act, and the respective rules thereunder, and, in with respect
to the Registration Statement only, the Trust Indenture Act of 1939, as amended, and the rules and regulations promulgated thereunder
(the &ldquo;Trust Indenture Act&rdquo;); on each Effective Date, at the Applicable Time and on the Closing Date, the Registration
Statement did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein not misleading; on the Effective Date and on the Closing Date,
the Indenture did or will comply in all material respects with the applicable requirements of the Trust Indenture Act and the rules
thereunder; and on the date of any filing pursuant to Rule 424(b) and on the Closing Date, the Prospectus (together with any supplement
thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>,
that the Company makes no representations or warranties as to (i) that part of the Registration Statement which shall constitute
the Statement of Eligibility (Form T-1) under the Trust Indenture Act of the Trustee or (ii) the information contained in or omitted
from the Registration Statement or the Prospectus (or any supplement thereto) in reliance upon and in conformity with information
furnished in writing to the Company by or on behalf of any Underwriter through the Representatives specifically for inclusion in
the Registration Statement or the Prospectus (or any supplement thereto), it being understood and agreed that the only such information
furnished by any Underwriter consists of the information described as such in Section 8 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
The Disclosure Package and (ii) each electronic road show listed on Schedule III, when taken together as a whole with the Disclosure
Package, do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not
apply to statements in or omissions from the Disclosure Package based upon and in conformity with written</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">information furnished to the Company
by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such
information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
At the time of filing the Registration Statement, (ii) at the time of the most recent amendment thereto for the purposes of complying
with Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed
pursuant to Sections 13 or 15(d) of the Exchange Act or form of prospectus), (iii) at the time the Company or any person acting
on its behalf (within the meaning, for this clause only, of Rule 163(c) of the Securities Act) made any offer relating to the Securities
in reliance on the exemption in Rule 163, and (iv) at the date hereof, the Company was and is a &ldquo;well-known seasoned issuer&rdquo;
as defined in Rule 405. The Company agrees to pay the fees required by the Commission relating to the Securities within the time
required by Rule 456(b)(1) without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
At the earliest time after the filing of the Registration Statement that the Company or another offering participant made a <I>bona
fide</I> offer (within the meaning of Rule 164(h)(2)) under the Securities Act and (ii) as of the Applicable Time (with such date
being used as the determination date for purposes of this clause (ii)), the Company was not and is not an Ineligible Issuer (as
defined in Rule 405).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
issuer free writing prospectus as defined in Rule 433 under the Securities Act (an &ldquo;Issuer Free Writing Prospectus&rdquo;)
and the final term sheet prepared and filed pursuant to Section 5(b) hereto does not include any information that conflicts with
the information contained in the Registration Statement, including any document incorporated by reference therein and any prospectus
supplement deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not apply to statements
in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the
Company by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only
such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
the respective dates as of which information is given in the Registration Statement, the Prospectus and the Disclosure Package,
there has not been any material change in the capital stock or long-term debt of the Company or any of its Significant Subsidiaries
(as defined in Rule 405 under the Securities Act) (other than changes arising from funding activities which have not resulted in
any material change in the Company&rsquo;s ownership of such Significant Subsidiaries or in the long term debt of the Company and
its subsidiaries taken as a whole) or any material adverse change, or any development involving a prospective material adverse
change, in or affecting the general affairs, consolidated financial position or consolidated results of operations of the Company,
otherwise than as set forth or contemplated in the Prospectus and the Disclosure Package.</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company (i) has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of
Delaware, with corporate power and authority to own its properties and conduct its business as described in the Prospectus and
the Disclosure Package, and has been duly qualified as a foreign corporation for the transaction of business and is in good standing
under the laws of each other jurisdiction in which it owns or leases properties, or conducts any business, so as to require such
qualification, except where the failure to be so qualified would not have a material adverse effect on the Company and its subsidiaries
taken as a whole; and each Significant Subsidiary of the Company has been duly incorporated and is validly existing as a corporation
and is in good standing under the laws of its jurisdiction of incorporation, (ii) has or, in the case of the Indenture, had the
requisite corporate power and authority to execute and deliver this Agreement, the Indenture and the Securities and has the requisite
corporate power and authority to perform its obligations hereunder and thereunder, and (iii) has duly authorized, executed and
delivered this Agreement and this Agreement constitutes the valid and binding agreement of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; border-bottom-width: 0pt; border-bottom-color: Black">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
the Securities are issued and delivered pursuant to this Agreement, such Securities will have been duly authorized, executed, authenticated,
issued and delivered and will constitute valid and legally binding obligations of the Company entitled to the benefits provided
by the Indenture; and the Indenture has been duly authorized by the Company and is duly qualified under the 1939 Act and constitutes
a valid and legally binding instrument, enforceable in accordance with its terms, subject to bankruptcy, insolvency, reorganization,
moratorium and other laws of general applicability relating to or affecting creditors&rsquo; rights and to general equitable principles
(regardless of whether enforcement is considered in a proceeding in equity or at law), and except further as enforcement thereof
may be limited by requirements that a claim with respect to any debt securities issued under the Indenture that are payable in
a foreign (or a foreign currency judgment in respect of such claim) be converted into U.S. dollars at a rate of exchange prevailing
on a date determined pursuant to applicable law or by governmental authority to limit, delay or prohibit the making of payments
outside the United States of America (&ldquo;United States&rdquo;); the paying agency agreement between the Company, The Bank of
New York Mellon, London Branch, (the &ldquo;Paying Agent&rdquo;), and the Trustee has been duly authorized by the Company and,
when executed and delivered by the Company (assuming the due authorization, execution and delivery by the Paying Agent and the
Trustee) will constitute a valid and legally binding instrument, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, reorganization, moratorium and other laws of general applicability relating to or affecting creditors&rsquo; rights
and to general equitable principles (regardless of whether enforcement is considered in a proceeding in equity or at law); and
the Securities and the Indenture will conform in all material respects to the descriptions thereof in the Prospectus and the Disclosure
Package.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
issue and sale of the Securities by the Company and the compliance by the Company with all of the provisions of this Agreement
and the Indenture and the consummation of the transactions herein and therein contemplated will not conflict with or result in
a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust,
loan agreement or other agreement</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt; border-bottom-width: 0pt; border-bottom-color: Black">or
instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound
or to which any of the property or assets of the Company or any of its subsidiaries is subject, which conflict, breach or default
would have a material adverse effect on the consolidated financial position or consolidated results of operations of the Company,
nor will such action result in (A) any violation of the provisions of the Certificate of Incorporation or By-laws of the Company
or any of its subsidiaries or (B) any violation of the provisions of any statute or any order, rule or regulation of any court
or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any of their properties, which
violation in each case would have a material adverse effect on the consolidated financial position or consolidated results of operations
of the Company; and no consent, approval, authorization, order, registration or qualification of or with any such court or governmental
agency or body is required for the issue and sale of the Securities or the consummation by the Company of the transactions contemplated
by this Agreement or the Indenture, except such consents, approvals, authorizations, registrations or qualifications as may be
required under the Securities Act and the Trust Indenture Act or under state or foreign securities or Blue Sky laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt; border-bottom-width: 0pt; border-bottom-color: Black">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
than as set forth or contemplated in the Prospectus and the Disclosure Package, there are no legal or governmental proceedings
pending to which the Company or any of its subsidiaries is a party or of which any property of the Company or any of its subsidiaries
is the subject, which are probable to result in an adverse determination and which, if determined adversely to the Company or any
of its subsidiaries, would individually or in the aggregate have a material adverse effect on the consolidated financial position
or consolidated results of operations of the Company; and, to the best of the Company&rsquo;s knowledge, no such proceedings are
threatened or contemplated by governmental authorities or threatened by others.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consolidated historical financial statements and schedules of the Company and its consolidated subsidiaries included in the Preliminary
Prospectus, the Prospectus and the Registration Statement present fairly in all material respects the financial condition, results
of operations and cash flows of the Company as of the dates and for the periods indicated, comply as to form in all material respects
with the applicable accounting requirements of the Securities Act and the Securities Act Regulations and have been prepared in
conformity with generally accepted accounting principles throughout the periods involved (except as otherwise noted therein).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PricewaterhouseCoopers
LLP, who have certified certain financial statements of the Company and its consolidated subsidiaries, are independent registered
public accountants as required by the Securities Act, the Securities Act Regulations and rules and regulations adopted by the Public
Company Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its subsidiaries own or possess, or can acquire on reasonable terms, the patents, patent rights, licenses, invention,
copyrights (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or
procedures), trademarks, service marks and trade names</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt; border-bottom-width: 0pt; border-bottom-color: Black">presently
employed by them in connection with the businesses now operated by them, except where the failure so to own or possess or have
the ability to acquire would not have a material adverse effect on the consolidated financial position or consolidated results
of operations of the Company, and neither the Company nor any of its subsidiaries has received any notice of infringement of or
conflict with asserted rights of others with respect to any of the foregoing which, singly or in the aggregate, if the subject
of an unfavorable decision, ruling or finding, would result in any material adverse effect on the consolidated financial position
or consolidated results of operations of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt; border-bottom-width: 0pt; border-bottom-color: Black">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is not, and upon the issuance and sale of the Securities as herein contemplated and the application of the net proceeds
therefrom as described in the Prospectus and the Disclosure Package will not be, an &ldquo;investment company&rdquo; within the
meaning of the Investment Company Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is in material compliance with all applicable provisions of the Sarbanes-Oxley Act of 2002 and all rules and regulations
promulgated thereunder or implementing the provisions thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are
executed in accordance with management&rsquo;s general or specific authorizations; (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset
accountability; (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization;
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences; and (v) the interactive data in XBRL included or incorporated by reference in the Registration
Statement, the Preliminary Prospectus and the Prospectus is in compliance with the Commission&rsquo;s published rules, regulations
and guidelines applicable thereto. The Company&rsquo;s internal control over financial reporting (as such term is defined in Rule
13a-15(f) of the Exchange Act) was effective as of December 31, 2020 and the Company was not, as of September 30, 2021, aware of
any material weaknesses or significant deficiencies in the design and operation of their internal control over financial reporting.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company maintains &ldquo;disclosure controls and procedures&rdquo; (as such term is defined in Rule 13a-15(e) under the Exchange
Act) designed to provide reasonable assurance that material information required to be disclosed by the Company in the reports
that it files or submits under the Exchange Act is communicated to the Company&rsquo;s management as appropriate to allow timely
decisions regarding required disclosure; and, as of September 30, 2021, such disclosure controls and procedures of the Company
were effective.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has not taken, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected
to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of the Securities.</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its subsidiaries are (i) in compliance with any and all applicable foreign, federal, state and local laws and regulations
relating to the protection of human health and safety (as it relates to exposure to hazardous or toxic substances) or the environment
or relating to hazardous or toxic substances or wastes, pollutants or contaminants (&ldquo;Environmental Laws&rdquo;), (ii) have
received and are in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws
to conduct their respective businesses and (iii) have not received written notice of any actual or potential liability under any
Environmental Law, except where such non-compliance with Environmental Laws, failure to receive required permits, licenses or other
approvals, or liability would not, individually or in the aggregate, have a material adverse effect on the consolidated financial
position or consolidated results of operations of the Company, except as set forth in or contemplated in the Disclosure Package
and the Prospectus (exclusive of any amendment or supplement thereto). Except as set forth in the Disclosure Package and the Prospectus,
neither the Company nor any of the subsidiaries has been named as a &ldquo;potentially responsible party&rdquo; under the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, as amended, except to the extent that being so named would not,
individually or in the aggregate, have a material adverse effect on the consolidated financial position or consolidated results
of operations of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; border-bottom-width: 0pt; border-bottom-color: Black">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, controlled
affiliate or other person acting on behalf of the Company or any of its subsidiaries is aware of or has taken within the preceding
five years any action, directly or indirectly, that could constitute a violation by such persons of the Foreign Corrupt Practices
Act of 1977 or the U.K. Bribery Act 2010, each as may be amended, or similar applicable law of any other relevant jurisdiction,
or the rules or regulations thereunder; it being understood that no representation is made as to any subsidiary of the Company
prior to the time it became a subsidiary, or as to any director, officer, agent, employee of the Company prior to the time he,
she or it became such; and the Company and its subsidiaries have instituted and maintain policies and procedures designed to ensure
compliance therewith, in all material respects. No part of the proceeds of the offering will be used, directly or indirectly, in
violation of the Foreign Corrupt Practices Act of 1977 or the U.K. Bribery Act 2010, each as may be amended, or similar applicable
law of any other relevant jurisdiction, or the rules or regulations thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
operations of the Company and its subsidiaries are and have been conducted at all times within the preceding five years in all
material respects in compliance with applicable money laundering statutes and the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency that has proper jurisdiction
(collectively, the &ldquo;Money Laundering Laws&rdquo;) and no action, suit or proceeding by or before any court or governmental
agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering
Laws is pending or, to the best knowledge of the Company, threatened.</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or
controlled affiliate of the Company or any of its subsidiaries (i) is, or is controlled or 50% or more owned in the aggregate by
or is acting on behalf of, one or more individuals or entities that are currently the subject of any sanctions administered or
enforced by the United States (including any administered or enforced by the Office of Foreign Assets Control of the U.S. Department
of the Treasury, the U.S. Department of State or the Bureau of Industry and Security of the U.S. Department of Commerce), the United
Nations Security Council, the European Union and the United Kingdom or other applicable sanctions authority (collectively, &ldquo;Sanctions&rdquo;
and such persons, &ldquo;Sanctioned Persons&rdquo; and each such person, a &ldquo;Sanctioned Person&rdquo;), (ii) is located, organized
or resident in a country or territory that is, or whose government is, the subject of comprehensive Sanctions (presently, Cuba,
Iran, North Korea, Syria and the Crimea Region collectively, &ldquo;Sanctioned Countries&rdquo; and each, a &ldquo;Sanctioned Country&rdquo;)
or (iii) will, directly or indirectly, knowingly use the proceeds of this offering, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other individual or entity in any manner that would result in a violation
of any Sanctions by, or could result in the imposition of Sanctions against, any individual or entity (including any individual
or entity participating in the offering, whether as underwriter, advisor, investor or otherwise).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; border-bottom-width: 0pt; border-bottom-color: Black">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Company nor any of its subsidiaries has engaged in any dealings or transactions with or for the benefit of a Sanctioned Person,
or with or in a Sanctioned Country, in the preceding three years, nor does the Company or any of its subsidiaries have any plans
to engage in dealings or transactions with or for the benefit of a Sanctioned Person, or with or in a Sanctioned Country, except
in a manner that complies with applicable Sanctions; it being understood that no representation is made as to any subsidiary of
the Company prior to the time it became a subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications and databases (collectively, &ldquo;IT Systems&rdquo;) are adequate for, and operate and perform in all
material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently
conducted. The Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures,
and safeguards designed to maintain and protect their material confidential information and the integrity, continuous operation,
redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or
regulated data (&ldquo;Personal Data&rdquo;)) used in connection with their businesses, and there have been no breaches, outages
or unauthorized uses of or accesses to IT Systems and Personal Data, except as would not individually or in the aggregate, have
a material adverse effect upon the operations or financial position of the Company. The Company and its subsidiaries are presently
in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of
IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation
or</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt; border-bottom-width: 0pt; border-bottom-color: Black">modification,
except as would not individually or in the aggregate, have a material adverse effect upon the operations or financial position
of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt; border-bottom-width: 0pt; border-bottom-color: Black">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">Any certificate signed by any officer of
the Company and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Securities
shall be deemed a representation and warranty by the Company, as to matters covered thereby, to each Underwriter.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Each of the Underwriters acknowledges, agrees
and confirms that the representations and warranties contained in paragraphs (v) and (w) of this Section 1 are only sought and
given to the extent that those provisions would not result in a violation of Council Regulation (EC) 2271/1996 (or, if applicable,
such regulation as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as
amended, the &ldquo;EUWA&rdquo;)) and/or any associated and applicable national law, instrument or regulation related thereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Purchase
and Sale</U>. Subject to the terms and conditions and in reliance upon the representations and warranties herein set forth, the
Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company,
at the purchase price set forth in Schedule I hereto, the principal amount of the Securities set forth opposite such Underwriter&rsquo;s
name in Schedule II hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Delivery
and Payment</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
net purchase price for all Securities to be purchased as provided herein will be paid by the Representatives to the Company at
9:00 A.M., London time, on November 10, 2021, or at such other time or place on the same or such other date as the Company and
the Representatives may agree (the &ldquo;Closing Date&rdquo;) in euros by wire transfer in same day funds, with any transfer taxes
payable in connection with the sale of the Securities to be duly paid by the Company, against the delivery of a global certificate
(the &ldquo;Registered Global Certificate&rdquo;), duly executed and registered in the name of The Bank of New York Depository
(Nominees) Limited, as nominee, and in or substantially in the form provided in the Indenture to The Bank of New York Mellon (London
Branch), as Common Depositary (the &ldquo;Common Depositary&rdquo;) for Euroclear Bank SA/NV (&ldquo;Euroclear&rdquo;) and Clearstream
Banking S.A. (&ldquo;Clearstream&rdquo;). The Registered Global Certificate will be made available for inspection by the Representatives
not later than 12:00 P.M., New York time, on the business day prior to the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Against
delivery of the Registered Global Certificate, the Representatives will, on the Closing Date, give instructions to the Common Depositary
to arrange for the payment to the Company on the Closing Date of the net purchase price for the Securities as aforesaid.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Offering
by Underwriters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is understood that the several Underwriters propose to offer the Securities for sale to the public as set forth in the Prospectus.</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Underwriter represents and agrees that: (i) it has not offered, sold or otherwise made available and will not offer, sell or otherwise
make available any Securities to any retail investor in the United Kingdom; (ii) it has only communicated or caused to be communicated
and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the
meaning of Section 21 of the Financial Services and Markets Act 2000 (as amended, the &ldquo;FSMA&rdquo;)) received by it in connection
with the issue or sale of the Notes in circumstances in which Section 21(1) of the FSMA would not apply to the Company; and (iii)
it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the
Notes in, from or otherwise involving the United Kingdom. For the purposes of this Section 2(b), the expression &ldquo;retail investor&rdquo;
means a person who is one (or more) of the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of
the EUWA; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement the Insurance
Distribution Directive (as defined in Section 2(c) below), where that customer would not qualify as a professional client, as defined
in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Underwriter represents and agrees that it has not offered, sold or otherwise made available and will not offer, sell or otherwise
make available any Securities to any retail investor in the European Economic Area. For the purposes of this Section 2(c):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
expression &ldquo;retail investor&rdquo; means a person who is one (or more) of the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 36pt">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
retail client as defined in point (11) of Article 4(1) of MiFID II; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 36pt">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
customer within the meaning of the Insurance Distribution Directive, where that customer would not qualify as a professional client
as defined in point (10) of Article 4(1) of MiFID II; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
expression &ldquo;MiFID II&rdquo; means Directive 2014/65/EU, as amended and the expression &ldquo;Insurance Distribution Directive&rdquo;
means Directive (EU) 2016/97, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Agreements</U>.
The Company agrees with the several Underwriters that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the termination of the offering of the Securities, the Company will not file any amendment of the Registration Statement or
supplement (including the Prospectus or any Preliminary Prospectus) to the Base Prospectus unless the Company has furnished you
a copy for your review prior to filing and will not file any such proposed amendment or supplement to which you reasonably object.
Subject to the foregoing sentence, the Company will cause the Prospectus, properly completed, and any</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">supplement thereto to be filed with
the Commission pursuant to the applicable paragraph of Rule 424(b) within the time period prescribed. The Company will promptly
advise the Representatives (i) when the Prospectus, and any supplement thereto, shall have been filed with the Commission pursuant
to Rule 424(b), (ii) when, prior to termination of the offering of the Securities, any amendment to the Registration Statement
shall have been filed or become effective, (iii) of any request by the Commission or its staff for any amendment of the Registration
Statement, or any Rule 462(b) Registration Statement, or for any supplement to the Prospectus or for any additional information,
(iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or of any notice
objecting to its use or the institution or threatening of any proceeding for that purpose and (v) of the receipt by the Company
of any notification with respect to the suspension of the qualification of the Securities for sale in any jurisdiction or the institution
or threatening of any proceeding for such purpose. The Company will use its reasonable efforts to prevent the issuance of any such
stop order and, if issued, to obtain as soon as possible the withdrawal thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will prepare a final term sheet, containing solely a description of final terms of the Securities and the offering thereof,
in the form approved by you and attached as Schedule V hereto and will file such term sheet pursuant to Rule 433(d) within the
time required by such rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
at any time prior to the filing of the Prospectus pursuant to Rule 424(b), any event occurs as a result of which the Disclosure
Package would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein in the light of the circumstances under which they were made or the circumstances then prevailing not misleading,
the Company will (i) notify promptly the Representatives so that any use of the Disclosure Package may cease until it is amended
or supplemented; (ii) amend or supplement the Disclosure Package to correct such statement or omission; and (iii) supply any amendment
or supplement to you in such quantities as you may reasonably request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
at any time when a prospectus relating to the Securities is required to be delivered under the Securities Act (including in circumstances
where such requirement may be satisfied pursuant to Rule 172), any event occurs as a result of which the Prospectus as then supplemented
would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
therein in the light of the circumstances under which they were made at such time not misleading, or if it shall be necessary to
amend the Registration Statement, file a new registration statement or supplement the Prospectus to comply with the Securities
Act or the Exchange Act or the respective rules thereunder, the Company promptly will (i) notify the Representatives of any such
event, (ii) prepare and file with the Commission, subject to the second sentence of paragraph (a) of this Section 5, an amendment
or supplement or new registration statement which will correct such statement or omission or effect such compliance and (iii) supply
any supplemented Prospectus to you in such quantities as you may reasonably request.</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
soon as practicable, the Company will make generally available to its security holders and to the Representatives an earnings statement
or statements of the Company and its subsidiaries which will satisfy the provisions of Section 11(a) of the Securities Act and
Rule 158 under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will furnish to the Representatives and counsel for the Underwriters, without charge, copies of the Registration Statement
(including exhibits thereto) and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the Securities
Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), as many copies of each Preliminary
Prospectus, the Prospectus and each Issuer Free Writing Prospectus and any supplement thereto as the Representatives may reasonably
request. The Company will pay the expenses of printing or other production of all documents relating to the offering.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will endeavor, in cooperation with the Representatives, if necessary, to qualify the Securities for sale under the laws
of such jurisdictions as the Representatives may designate and will maintain such qualifications in effect so long as required
for the distribution of the Securities; provided that in no event shall the Company be obligated to qualify to do business in any
jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits, other
than those arising out of the offering or sale of the Securities, in any jurisdiction where it is not now so subject.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Between
the date of this Agreement and the Closing Date, the Company will not, without the prior written consent of the Representatives,
directly or indirectly, sell, offer to sell, contract to sell or otherwise dispose of, or announce the offering of, any debt securities
denominated in the same currency as the Securities, or any security exchangeable into such debt securities (other than the Securities
and commercial paper in the ordinary course of business).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to pay the costs and expenses relating to the following matters: (i) the preparation, printing or reproduction and
filing with the Commission of the Registration Statement (including financial statements and exhibits thereto), each Preliminary
Prospectus, the Prospectus and each Issuer Free Writing Prospectus, and each amendment or supplement to any of them; (ii) the printing
(or reproduction) and delivery (including postage, air freight charges and charges for counting and packaging) of such copies of
the Registration Statement, each Preliminary Prospectus, the Prospectus and each Issuer Free Writing Prospectus, and all amendments
or supplements to any of them, as may, in each case, be reasonably requested for use in connection with the offering and sale of
the Securities; (iii) the preparation, printing, authentication, issuance and delivery of certificates for the Securities, including
any stamp or transfer taxes in connection with the original issuance and sale of the Securities; (iv) the printing (or reproduction)
and delivery of this Agreement, any blue sky memorandum and all other agreements or documents printed (or reproduced) and delivered
in connection with the offering of the Securities; (v) the registration of the Securities under the Exchange Act and the listing
of the Securities on the New York Stock Exchange, Inc. (the &ldquo;NYSE&rdquo;); (vi) any registration or qualification of the
Securities</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">for offer and sale under the securities
or blue sky laws of the several states (including filing fees and the reasonable fees and expenses of counsel for the Underwriters
relating to such registration and qualification); (vii) any filings required to be made with the Financial Industry Regulatory
Authority, Inc. (&ldquo;FINRA&rdquo;) (including filing fees and the reasonable fees and expenses of counsel for the Underwriters
relating to such filings); (viii) the transportation and other expenses incurred by or on behalf of Company representatives in
connection with presentations to prospective purchasers of the Securities; (ix) the fees and expenses of the Company&rsquo;s accountants
and the fees and expenses of counsel (including local and special counsel) for the Company; and (x) all other costs and expenses
incurred by the Company incident to the performance by the Company of its obligations hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees that, unless it has or shall have obtained the prior written consent of the Representatives, and each Underwriter,
severally and not jointly, agrees with the Company that, unless it has or shall have obtained, as the case may be, the prior written
consent of the Company, it has not made and will not make any offer relating to the Securities that would constitute an Issuer
Free Writing Prospectus or that would otherwise constitute a Free Writing Prospectus required to be filed by the Company with the
Commission or retained by the Company under Rule 433 under the Securities Act (&ldquo;Rule 433&rdquo;), other than a free writing
prospectus containing the information contained in the final term sheet specified in Section 5(b) hereto; provided that the prior
written consent of the parties hereto shall be deemed to have been given in respect of the Permitted Free Writing Prospectuses
included in Schedule IV hereto and any electronic road show. The Company agrees that (x) it has treated and will treat, as the
case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y) it has complied and will comply,
as the case may be, with the requirements of Rule 164 under the Securities Act (&ldquo;Rule 164&rdquo;) and Rule 433 applicable
to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
net proceeds from the sale of Securities will be used by the Company as described in the Prospectus and the Disclosure Package.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will use its reasonable best efforts to cause the Securities to be listed for trading on the NYSE as promptly as practicable
after the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will cooperate with the Underwriters and use its reasonable best efforts to permit the Securities to be eligible for clearance
and settlement through Clearstream and Euroclear.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conditions
to the Obligations of the Underwriters</U>. The obligations of the Underwriters to purchase the Securities shall be subject to
the accuracy of the representations and warranties in all material respects (to the extent any such representation or warranty
is not otherwise qualified therein) on the part of the Company contained herein as of the Applicable Time and the Closing Date,
to the accuracy of the statements of the Company made in any certificates pursuant to the provisions hereof, to the performance
by the Company of its obligations hereunder and to the following additional conditions:</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Prospectus, and any supplement thereto, have been filed in the manner and within the time period required by Rule 424(b); the final
term sheet contemplated by Section 5(b) hereto and any other material required to be filed by the Company pursuant to Rule 433(d)
shall have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; and no stop
order suspending the effectiveness of the Registration Statement or any notice objecting to its use shall have been issued and
no proceedings for that purpose shall have been instituted or threatened.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have requested and caused Hogan Lovells US LLP, counsel for the Company, to have furnished to the Representatives
their opinion, dated the Closing Date and addressed to the Representatives, to the effect set forth in <U>Exhibit A</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representatives shall have received from Mayer Brown LPP, counsel for the Underwriters, such opinion or opinions, dated the Closing
Date and addressed to the Representatives, with respect to the issuance and sale of the Securities, the Indenture, the Registration
Statement, the Disclosure Package, the Prospectus (together with any supplement thereto) and other related matters as the Representatives
may reasonably require, and the Company shall have furnished to such counsel such documents as they request for the purpose of
enabling them to pass upon such matters.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have furnished to the Representatives a certificate of the Company, signed by the President or any Vice President
and the chief financial, chief accounting officer or treasurer of the Company, dated the Closing Date, to the effect that (i) since
the respective dates as of which information is given in the Registration Statement and the Prospectus or since the date of this
Agreement, there has not been any material adverse change, or any development involving a prospective material adverse change,
in or affecting the general affairs, consolidated financial position or consolidated results of operations of the Company and its
subsidiaries, considered as one enterprise, whether or not arising in the ordinary course of business, otherwise than as set forth
or contemplated in the Prospectus, (ii) the other representations and warranties of the Company contained in Section 1 hereof are
true and correct with the same force and effect as though expressly made at and as of the date of such certificate, (iii) the Company
has performed or complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at
or prior to the date of such certificate, and (iv) no stop order suspending the effectiveness of the Registration Statement has
been issued and, to their knowledge, no proceedings for that purpose have been initiated or threatened by the Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PricewaterhouseCoopers
LLP shall have furnished to the Representatives, at the Applicable Time and at the Closing Date, letters (which may refer to letters
previously delivered to one or more of the Representatives), dated respectively as of the Applicable Time and as of the Closing
Date, in form and substance satisfactory to the Representatives containing statements and information of the type customarily included
in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect to the financial statements and certain financial
information contained or incorporated by reference in the Registration Statement and the Prospectus.</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Closing Date, the Company shall have furnished to the Representatives such further information, certificates and documents
as the Representatives may reasonably request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsequent
to the execution and delivery of this Agreement and prior to the Closing Date, there shall not have been any decrease in the rating
of any of the Company&rsquo;s debt securities by any &ldquo;nationally recognized statistical rating organization&rdquo; (as defined
for purposes of Rule 3(a)(62) under the Exchange Act) or any notice given of any intended or potential decrease in any such rating
or of a possible change in any such rating that does not indicate the direction of the possible change.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">If any of the conditions specified in this
Section 6 shall not have been fulfilled when and as required to be fulfilled, this Agreement and all obligations of the Underwriters
hereunder may be canceled at, or at any time prior to, the Closing Date by the Representatives. Notice of such cancellation shall
be given to the Company in writing or by telephone or facsimile confirmed in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The documents required to be delivered by
this Section 6 shall be delivered at the office of Mayer Brown LLP, counsel for the Underwriters, at 1221 Avenue of the Americas,
New York, New York 10020, on the Closing Date or by facsimile or electronic mail (including pdf or any electronic signature complying
with the New York Electronic Signatures and Records Act (N.Y. State Tech. &sect;&sect; 301-309), as amended from time to time,
or other applicable law) or other transmission method, and the parties hereto agree that any document so delivered shall be deemed
to have been duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Reimbursement
of Underwriters&rsquo; Expenses</U>. If the sale of the Securities provided for herein is not consummated because any condition
to the obligations of the Underwriters set forth in Section 6 hereof is not satisfied, because of any termination pursuant to Section
10 hereof or because of any refusal, inability or failure on the part of the Company to perform any agreement herein or comply
with any provision hereof other than by reason of a default by any of the Underwriters, the Company will reimburse the Underwriters
severally through the Representatives on demand for all out-of-pocket expenses (including reasonable fees and disbursements of
counsel) that shall have been reasonably incurred by them in connection with the proposed purchase and sale of the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt"><FONT STYLE="text-transform: uppercase">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Indemnification
and Contribution</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to indemnify and hold harmless each Underwriter, the directors, officers, employees and affiliates of each Underwriter
and each person, if any, who controls each Underwriter within the meaning of either the Securities Act or the Exchange Act against
(i) any and all losses, claims, damages or liabilities, incurred, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon (A) any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement as originally filed or in any amendment thereof, or the omission or alleged omission therefrom of
a material fact required to be stated therein or necessary to make the statements therein not misleading or (B) any untrue statement
or alleged untrue statement of a material fact contained in the</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">Base Prospectus, any Preliminary
Prospectus or any other preliminary prospectus supplement relating to the Securities, the Prospectus, any Issuer Free Writing Prospectus
(or any amendment or supplement thereto) or any electronic road show listed on Schedule III the omission or alleged omission therefrom
of a material fact necessary to make statements therein, in the light of the circumstances under which they were made, not misleading;
(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount
paid in settlement of any litigation, or investigation or proceeding by any governmental agency or body, commenced or threatened,
or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission,
if such settlement is effected with the written consent of the Company; and (iii)<B> </B>against any and all reasonable expense
whatsoever, as incurred (including the reasonable fees and disbursements of counsel chosen by an Underwriter), reasonably incurred
in investigating, preparing or defending against any litigation, or investigation or proceeding by any governmental agency or body,
commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement
or omission, to the extent that any such expense is not paid under (i) or (ii) above;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-indent: 72pt"><U>provided</U>, <U>however</U>,
that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of
or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance
upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representatives
specifically for inclusion therein, it being understood and agreed that the only such information furnished by or on behalf of
any Underwriter consists of the information described in Section 8(b) below. This indemnity agreement will be in addition to any
liability which the Company may otherwise have.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, each of its directors, each of its officers
who signs the Registration Statement, and each person who controls the Company within the meaning of either the Securities Act
or the Exchange Act, to the same extent as the foregoing indemnity included in Section (a) of this Section from the Company to
each Underwriter, but only with reference to written information relating to such Underwriter furnished to the Company by or on
behalf of such Underwriter through the Representatives specifically for inclusion in the documents referred to in the foregoing
indemnity included in subsection (a) of this Section. This indemnity agreement will be in addition to any liability which any Underwriter
may otherwise have. The Company acknowledges that the statements set forth in the first paragraph under the heading &ldquo;Underwriting&mdash;Commissions
and Discounts,&rdquo; the second sentence of the first paragraph under the heading &ldquo;Underwriting&mdash;New Issue of Notes&rdquo;
and the first and second paragraphs under the heading &ldquo;Underwriting&mdash;Other Relationships&rdquo; in any Preliminary Prospectus
and the Prospectus constitute the only information furnished in writing by or on behalf of the several Underwriters for inclusion
in any Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly
after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, such indemnified party
will, if a claim in</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">respect thereof is to be made against
the indemnifying party under this Section 8, notify the indemnifying party in writing of the commencement thereof; but the failure
so to notify the indemnifying party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to the extent
it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights
and defenses and (ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other
than the indemnification obligation provided in paragraph (a) or (b) above. The indemnifying party shall be entitled to appoint
counsel of the indemnifying party&rsquo;s choice at the indemnifying party&rsquo;s expense to represent the indemnified party in
any action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the
fees and expenses of any separate counsel retained by the indemnified party or parties except as set forth below); <U>provided</U>, <U>however</U>, that such counsel shall be satisfactory to the indemnified party. In any such proceeding, any indemnified party
shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified
party unless (i) the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel or
(ii) the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified
party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests
between them. In no event shall the indemnifying parties be liable for the fees and expenses of more than one counsel (in addition
to any local counsel) for all indemnified parties in connection with any one action or separate but similar or related actions
in the same jurisdiction arising out of the same general allegations or circumstances. An indemnifying party will not, without
the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect
to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought
hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement,
compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such claim,
action, suit or proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act,
by or on behalf of any indemnified party.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that the indemnity provided in paragraph (a), (b) or (c) of this Section 8 is unavailable to or insufficient to hold
harmless an indemnified party for any reason, the Company and the Underwriters severally agree to contribute to the aggregate losses,
claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending
the same) (collectively, &ldquo;<U>Losses</U>&rdquo;) to which the Company and one or more of the Underwriters may be subject in
such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and by the Underwriters
on the other from the offering of the Securities. If the allocation provided by the immediately preceding sentence is unavailable
for any reason, the Company and the Underwriters severally shall contribute in such proportion as is appropriate to reflect not
only such relative benefits but also the relative fault of the Company on the one hand and of the Underwriters on the other in
connection with the</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">statements or omissions which resulted
in such Losses as well as any other relevant equitable considerations. Benefits received by the Company shall be deemed to be equal
to the total net proceeds from the offering (before deducting expenses) received by it, and benefits received by the Underwriters
shall be deemed to be equal to the total underwriting discounts and commissions, in each case as set forth on the cover page of
the Prospectus. Relative fault shall be determined by reference to, among other things, whether any untrue or any alleged untrue
statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the
Company on the one hand or the Underwriters on the other, the intent of the parties and their relative knowledge, access to information
and opportunity to correct or prevent such untrue statement or omission. Notwithstanding the provisions of this paragraph (d),
in no event shall any Underwriter be required to contribute any amount in excess of the amount by which the total price at which
the Securities sold by such Underwriter to which such loss, claim, damage or liability relates and distributed to the public exceeds
the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement
or omission or alleged omission Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. For purposes of this Section 8, each person who controls an Underwriter within the meaning
of either the Securities Act or the Exchange Act and each director, officer, employee and affiliate of an Underwriter shall have
the same rights to contribution as such Underwriter, and each person who controls the Company within the meaning of either the
Securities Act or the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director
of the Company shall have the same rights to contribution as the Company, subject in each case to the applicable terms and conditions
of this paragraph (d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Default
by an Underwriter</U>. If one or more of the Underwriters shall fail on the Closing Date to purchase the Securities (the &ldquo;Defaulted
Securities&rdquo;), then the non-defaulting Underwriters shall have the right, within 24 hours thereafter, to make arrangements
for one of them or one or more other Underwriters to purchase all, but not less than all, of the Defaulted Securities in such amounts
as may be agreed upon and upon the terms herein set forth; provided however, that if such arrangements shall not have been completed
within such 24-hour period, then:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the aggregate principal amount of Defaulted Securities does not exceed 10% of the aggregate principal amount of Securities, the
non-defaulting Underwriters shall be obligated, severally and not jointly, to purchase the full amount thereof in the proportions
that their respective initial obligations under this Agreement bear to the obligations of all non-defaulting Underwriters under
this Agreement; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the aggregate principal amount of Defaulted Securities exceed 10% of the aggregate principal amount of Securities, this Agreement
shall terminate without liability on the part of any non-defaulting Underwriters.</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">No action taken pursuant to this Section
9 shall relieve any defaulting Underwriter from liability in respect of its default. In the event of any such default which does
not result in a termination of this Agreement, either the non-defaulting Underwriters or the Company shall have the right to postpone
the Closing Date of Delivery for a period not exceeding seven days in order to effect any required changes in the Registration
Statement or the Prospectus or in any other documents or arrangements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination</U>.
The Underwriters may terminate this Agreement, upon notice given to the Company prior to delivery of and payment for the Securities,
if at any time prior to such delivery and payment (i) there has been, since the date of this Agreement or since the respective
dates as of which information is given in the Registration Statement, any material change in the capital stock or long-term debt
of the Company or any of its subsidiaries or any material adverse change, or any development involving a prospective material adverse
change, in or affecting the general affairs, consolidated financial position or consolidated results of operations of the Company,
whether or not arising in the ordinary course of business, or (ii) there shall have occurred any material adverse change in the
financial markets in the United States or in the international financial markets, or any outbreak or escalation of hostilities
or other calamity or crisis the effect of which on the financial markets of the United States or on the international financial
markets, in each case is such as to make it, in the reasonable judgment of the Representatives (after consultation with the Company),
impracticable to market the Securities subject to this Agreement or enforce contracts for the sale of such Securities, or (iii)
trading in any securities of the Company has been suspended by the Commission or a national securities exchange, or if trading
generally on the New York Stock Exchange shall have been suspended, or minimum or maximum prices for trading have been fixed, or
maximum ranges for prices for securities have been required, by either of said exchanges or by order of the Commission or any other
governmental authority, or if a banking moratorium shall have been declared by federal or New York authorities or if a banking
moratorium shall have been declared by European Union authorities, or (iv) the rating assigned by any nationally recognized securities
rating agency to any debt securities of the Company as of the date of this Agreement shall have been lowered since that date or
if any such rating agency shall have publicly announced since that date that it has placed any debt securities of the Company on
what is commonly termed a &ldquo;watch list&rdquo; for possible downgrading, or (v) the Prospectus, at the time it was required
to be delivered to a purchaser of Securities, contained an untrue statement of a material fact or omitted to state a material fact
necessary in order to make the statements therein, in the light of the circumstances existing at the time of such delivery, not
misleading.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Representations
and Indemnities to Survive</U>. The respective agreements, representations, warranties, indemnities and other statements of the
Company or any of its officers made in any certificate signed by any such officer of the Company and delivered to the Representatives
or counsel for the Underwriters pursuant to this Agreement and of the Underwriters set forth in or made pursuant to this Agreement
will remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter or any of the officers,
directors, employees, affiliates or controlling persons referred to in Section 8 hereof or the Company, and will survive delivery
of and payment for the Securities. The provisions of Sections 7 and 8 hereof shall survive the termination or cancellation of this
Agreement.</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices</U>.
All communications hereunder will be in writing and effective only on receipt, and, if sent to the Representatives, will be mailed,
delivered, telefaxed or transmitted and confirmed by any standard form of communication to: Citigroup Global Markets Limited, Citigroup
Centre, Canada Square, Canary Wharf, London E14 5LB, United Kingdom, Attention: Syndicate Desk, Fax: +44 (0)20 7986 1927 and Banco
Bilbao Vizcaya Argentaria, S.A., Ciudad BBVA, C/ Sauceda, 28, Edificio Asia - 2nd Floor, 28050, Madrid, Spain, Attention: DCM Originations,
Fax: +44 (0)20 7986 1927 or, if sent to the Company, will be mailed, delivered or telefaxed to Colgate-Palmolive Company, 300 Park
Avenue, New York, New York 10022, Attention: Treasurer, Email: colgate_treasury_back_office@colpal.com.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successors</U>.
This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers,
directors, employees, affiliates and controlling persons referred to in Section 8 hereof, and no other person will have any right
or obligation hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Recognition
of the U.S. Special Resolution Regimes</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime,
the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective
to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such
interest and obligation, were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding
under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are
permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime
if this Agreement were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">As used in this Section 14:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;BHC Act Affiliate&rdquo;
has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12 U.S.C. &sect;
1841(k).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;Covered Entity&rdquo; means
any of the following: (i) a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
&sect; 252.82(b), (ii) a &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect;
47.3(b) or (iii) a &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;Default Right&rdquo; has
the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1,
as applicable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;U.S. Special Resolution
Regime&rdquo; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II
of the</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">Dodd-Frank Wall Street Reform and
Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Fiduciary Duty</U>. The Company hereby acknowledges that the Underwriters will be acting pursuant to a contractual relationship
on an arm&rsquo;s length basis and in no event do the parties intend that the Underwriters act or be responsible as a fiduciary
to the Company, its management, stockholders, creditors or any other person. The Company and the Underwriters each hereby expressly
disclaim any fiduciary relationship and agree they are each responsible for making their own judgments with respect to any transactions
entered into between them.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Integration</U>.
This Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company and the Underwriters,
or any of them, with respect to the subject matter hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Applicable
Law</U>. This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts
made and to be performed within the State of New York.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Jurisdiction.
</U>The Company and the Underwriters agree that any suit, action or proceeding, arising out of or based upon this Agreement or
the transactions contemplated hereby may be instituted in any State or U.S. federal court in The City of New York and County of
New York, and waive any objection which they may now or hereafter have to the laying of venue of any such proceeding, and irrevocably
submit to the non-exclusive jurisdiction of such courts in any suit, action or proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Waiver
of Jury Trial</U>. The Company and the Underwriters hereby irrevocably waive, to the fullest extent permitted by applicable law,
any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Counterparts</U>.
This Agreement may be signed in one or more counterparts <FONT STYLE="background-color: white">(which may include counterparts
delivered by any standard form of telecommunication)</FONT>, each of which shall constitute an original and all of which together
shall constitute one and the same agreement. <FONT STYLE="background-color: white">Delivery of an executed Agreement by one party
to any other party may be made by facsimile, electronic mail (including any electronic signature complying with the New York Electronic
Signatures and Records Act (N.Y. State Tech. &sect;&sect; 301-309), as amended from time to time, or other applicable law) or other
transmission method, and the parties hereto agree that any counterpart so delivered shall be deemed to have been duly and validly
delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Headings</U>.
The section headings used herein are for convenience only and shall not affect the construction hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Contractual
Recognition of Bail-In (EEA)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">Notwithstanding and to the exclusion of any
other term of this agreement (&ldquo;Agreement&rdquo;) or any other agreements, arrangements or understanding among the parties
to this</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">Agreement, each of the parties to this Agreement acknowledges
and accepts that a BRRD Liability arising under this Agreement may be subject to the exercise of Bail-in Powers by the Relevant
Resolution Authority and acknowledges, accepts and agrees to be bound by:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
effect of the exercise of Bail-in Powers by the Relevant Resolution Authority in relation to any BRRD Liability of the Underwriters
to the Company under this Agreement, which (without limitation) may include and result in any of the following or some combination
thereof: (w) the reduction of all, or a portion, of the BRRD Liability or outstanding amounts due thereon; (x) the conversion of
all, or a portion, of the BRRD Liability into shares, other securities or other obligations of the Underwriters or another person
(and the issue to or conferral on the Company of such shares, securities or obligations); (y) the cancellation of the BRRD Liability;
and/or (z) the amendment or alteration of any interest, if applicable, thereon, the maturity or the dates on which any payments
are due, including by suspending payment for a temporary period; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(ii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
variation of the terms of this Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise
of Bail-in Powers by the Relevant Resolution Authority.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">As used in this Section 21,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;Bail-in Legislation&rdquo;
means in relation to a member state of the European Economic Area which has implemented, or which at any time implements, the BRRD,
the relevant implementing law, regulation, rule or requirement as described in the EU Bail-in Legislation Schedule from time to
time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;Bail-in Powers&rdquo; means
any Write-down and Conversion Powers as defined in the EU Bail-in Legislation Schedule, in relation to the relevant Bail-in Legislation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;BRRD&rdquo; means Directive
2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;BRRD Liability&rdquo; means
a liability in respect of which the relevant Bail-in Powers in the applicable Bail-in Legislation may be exercised.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;EU Bail-in Legislation Schedule&rdquo;
means the document described as such, then in effect, and published by the Loan Market Association (or any successor person) from
time to time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&ldquo;Relevant Resolution Authority&rdquo;
means the resolution authority with the ability to exercise any Bail-in Powers in relation to the relevant BRRD Party.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Contractual
Recognition of Bail-In (UK)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">Notwithstanding and to the exclusion of any
other term of this Agreement or any other agreements, arrangements or understanding among the parties to this Agreement, each of
the parties to this Agreement acknowledges and accepts that a UK Bail-in Liability arising under</P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">this Agreement may be subject to the exercise of UK Bail-in
Powers by the relevant United Kingdom (&ldquo;UK&rdquo;) resolution authority, and acknowledges, accepts and agrees to be bound
by:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
effect of the exercise of UK Bail-in Powers by the relevant UK resolution authority in relation to any UK Bail-in Liability of
the Underwriters to the Company under this Agreement, which (without limitation) may include and result in any of the following
or some combination thereof: (w) the reduction of all, or a portion, of the UK Bail-in Liability or outstanding amounts due thereon;
(x) the conversion of all, or a portion, of the UK Bail-in Liability into shares, other securities or other obligations of the
Underwriters or another person (and the issue to or conferral on the Company of such shares, securities or obligations); (y) the
cancellation of the UK Bail-in Liability; and/or (z) the amendment or alteration of any interest, if applicable, thereon, the maturity
or the dates on which any payments are due, including by suspending payment for a temporary period; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
variation of the terms of this Agreement, as deemed necessary by the relevant UK resolution authority, to give effect to the exercise
of UK Bail-in Powers by the relevant UK resolution authority.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">As used in this Section 22:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt">&ldquo;UK Bail-in Legislation&rdquo; means Part I of
the UK Banking Act 2009 and any other law or regulation applicable in the UK relating to the resolution of unsound or failing banks,
investment firms or other financial institutions or their affiliates (otherwise than through liquidation, administration or other
insolvency proceedings).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt">&ldquo;UK Bail-in Liability&rdquo; means a liability
in respect of which the UK Bail-in Powers may be exercised.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt">&ldquo;UK Bail-in Powers&rdquo; means the powers under
the UK Bail-In Legislation to cancel, transfer or dilute shares issued by a person that is a bank or investment firm or affiliate
of a bank or investment firm, to cancel, reduce, modify or change the form of a liability of such a person or any contract or instrument
under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person
or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it
or to suspend any obligation in respect of that liability.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Manufacturer
Acknowledgement (EEA)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">[Intentionally Left Blank]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Manufacturer
Acknowledgement (UK)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">Solely for the purposes of the requirements
of 3.2.7R of the FCA Handbook Product Intervention and Product Governance Sourcebook (the &ldquo;UK MiFIR Product Governance</P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">Rules&rdquo;) regarding the mutual responsibilities of manufacturers
under the UK MiFIR Product Governance Rules:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">Citigroup Global Markets Limited and Banco
Bilbao Vizcaya Argentaria, S.A. (the &ldquo;UK Manufacturers&rdquo;) each acknowledges that it understands the responsibilities
conferred upon it under the UK MiFIR Product Governance Rules relating to each of the product approval process, the target market
and the proposed distribution channels as applying to the Securities and the related information set out in the prospectus supplement
and announcements in connection with the Securities; and the other Underwriters and the Company note the application of the UK
MiFIR Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Securities
by the UK Manufacturer and the related information set out in the prospectus supplement and announcements in connection with the
Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt"><FONT STYLE="text-transform: uppercase">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Agreement
Among Underwriters; Stabilization</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By
executing this Agreement, each of the Underwriters hereby agrees to be bound by the provisions of the ICMA Agreement Among Managers
Version 1: Fixed-Price Non Equity-Related Issues - New York Law Schedule (the &ldquo;AAM&rdquo;), except that clause 3 of the AAM
shall not apply and, in the event of any conflict between the provisions of the AAM and this Agreement, the terms of this Agreement
shall prevail. For the purposes of the AAM, &ldquo;Managers&rdquo; means the Underwriters and &ldquo;Lead Managers&rdquo; means
Citigroup Global Markets Limited and Banco Bilbao Vizcaya Argentaria, S.A., &ldquo;Settlement Lead Manager&rdquo; and &ldquo;Stabilizing
Manager&rdquo; means Citigroup Global Markets Limited and &ldquo;Subscription Agreement&rdquo; means this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company hereby confirms the appointment of Citigroup Global Markets Limited in its role as stabilizing manager (the &ldquo;Stabilizing
Manager&rdquo;) and as the central point responsible for adequate public disclosure of information, and handling any request from
a competent authority, in accordance with Article 6(5) of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 with regard
to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures as it forms part
of the domestic law of the United Kingdom by virtue of the EUWA. The Stabilizing Manager for its own account may, to the extent
permitted by applicable laws and directives, over-allot and effect transactions with a view to supporting the market price of the
Purchased Securities at a level higher than that which might otherwise prevail, but in doing so the Stabilizing Manager shall act
as principal and not as agent of the Company and any loss resulting from overallotment and stabilization shall be borne, and any
profit arising therefrom shall be beneficially retained, by the Stabilizing Manager. However, stabilization may not necessarily
occur. Nothing contained in this paragraph shall be construed so as to require the Company to issue in excess of the aggregate
principal amount of Securities specified in Schedule I hereto. Such stabilization, if commenced, may cease at any time and shall
be conducted by the Stabilizing Manager in accordance with all applicable laws and directives.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 72pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to indemnify the Underwriters against any loss incurred by the Underwriters as a result of any judgment or order
being given or made for the amount due under this Agreement and such judgment or order being paid in a currency (a</P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt">&ldquo;Judgment Currency&rdquo;) other
than U.S. dollars as a result of any variation between (i) the rate of exchange at which U.S. dollars are converted into the Judgment
Currency for the purpose of such judgment or order and (ii) the rate of exchange at which the applicable Underwriter is able to
purchase U.S. dollars with the amount of the Judgment Currency actually received by such Underwriter. The foregoing indemnity included
in subsection (a) of this Section shall constitute a separate and independent obligation of the Company and shall continue in full
force and effect notwithstanding any such judgment or order as aforesaid. The term &ldquo;rate of exchange&rdquo; shall include
any premiums and costs of exchange payable in connection with the purchase of, or conversion into, the relevant currency.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Remainder of page intentionally left
blank; signatures appear on following pages]</I></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">If the foregoing is in accordance with your understanding
of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent
a binding agreement among the Company and the several Underwriters.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 12pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: justify">Very truly yours,</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom">COLGATE-PALMOLIVE COMPANY</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 65%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 4%">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 28%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">By:&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1px solid">/s/ Stephane Lionnet</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom">Name: &nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top">Stephane Lionnet</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: top">Title:</TD>
    <TD STYLE="vertical-align: top">Vice President and <BR>
Corporate Treasurer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">The foregoing Agreement is hereby<BR>
confirmed and accepted as of the date<BR>
specified in Schedule I hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">CITIGROUP GLOBAL MARKETS LIMITED</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD>By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; border-bottom: Black 1px solid">/s/ Simi Alabi</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%">Name:&nbsp; </TD>
    <TD STYLE="vertical-align: top; width: 94%">Simi Alabi</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom">Title:</TD>
    <TD STYLE="vertical-align: top">Delegated Signatory</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">BANCO BILBAO VIZCAYA ARGENTARIA, S.A.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0pt; padding-left: 0pt; border-bottom: Black 1px solid">/s/ Alvaro Solis</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: top; width: 94%; padding-right: 0pt; padding-left: 0pt">Alvaro Solis</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD NOWRAP STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Managing Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0pt; padding-left: 0pt; border-bottom: Black 1px solid">/s/ Andreas Kosse</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name:&nbsp; </TD>
    <TD STYLE="vertical-align: top; width: 94%; padding-right: 0pt; padding-left: 0pt">Andreas Kosse</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Managing Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">ANZ SECURITIES, INC.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0pt; padding-left: 0pt; border-bottom: Black 1px solid">/s/ Morgan Griffiths</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%; padding-right: 0pt; padding-left: 0pt">Morgan Griffiths</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Vice President</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Underwriting Agreement</I>]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt"></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">BANCO SANTANDER, S.A.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Matthias Dhaene</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Matthias Dhaene</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Authorised Signatory</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Alexis Rohr</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Alexis Rohr</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Authorised Signatory</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">BARCLAYS BANK PLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Lynda Fleming</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Lynda Fleming</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Vice President</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">BNP PARIBAS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Hugh Pryse-Davies</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Hugh Pryse-Davies</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Authorised Signatory</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Benedict Foster</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Benedict Foster</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Authorised Signatory</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt"></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">BNY MELLON CAPITAL MARKETS, LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Dan Klinger</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Dan Klinger</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Managing Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">GOLDMAN SACHS &amp; CO. LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Ashley Everett</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Ashley Everett</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Managing Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt"></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">HSBC Bank plc</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Karl Allen</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Karl Allen</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Managing Associate </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0pt; padding-left: 0pt">General Counsel</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt"></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">ICBC STANDARD BANK PLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Marc Giesen</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Marc Giesen</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Head of Primary Markets</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>




<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">J.P. MORGAN SECURITIES PLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Robert Chambers</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Robert Chambers</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Executive Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt"></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">MERRILL LYNCH INTERNATIONAL</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Angus Reynolds</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Angus Reynolds</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Managing Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">MORGAN STANLEY &amp; CO. INTERNATIONAL
PLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Rachel Holdstock</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Rachel Holdstock</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Executive Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">U.S. BANCORP INVESTMENTS, INC.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ William J. Carney</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">William J. Carney</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Managing Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">WELLS FARGO SECURITIES INTERNATIONAL
LIMITED</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Damon Mahon</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Damon Mahon</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Managing Director</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt"></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">CASTLEOAK SECURITIES, L.P.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Philip Ippolito</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Philip Ippolito</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Executive Vice President</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">SIEBERT WILLIAMS SHANK &amp; CO.
LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">By:&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt">/s/ Arion Williams</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 1%; padding-right: 0pt; padding-left: 0pt">Name: &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 94%;  padding-right: 0pt; padding-left: 0pt">Arions Williams</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt">Title:</TD>
    <TD STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt">Senior Vice President</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-indent: -16.2pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 16.2pt; text-align: center; text-indent: -16.2pt">[<I>Signature
Page to Underwriting Agreement</I>]</P>




<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>SCHEDULE&nbsp;I</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Underwriting Agreement dated November 3, 2021</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Registration Statement No. 333-249768</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 10%">Representative(s):&nbsp;</TD>
    <TD STYLE="width: 90%">Citigroup Global Markets Limited</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Banco Bilbao Vizcaya Argentaria, S.A.</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Title, Purchase Price and Description of Securities:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">Title: 0.300% Senior Notes due 2029</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">Principal amount: &euro;500,000,000</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">Purchase price (include accrued interest or amortization,
if any): 99.326%</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">Sinking fund provisions: None</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">Redemption provisions: As provided in the Preliminary Prospectus
and final term sheet prepared and filed pursuant to Section 5(b)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">Other provisions: See the Preliminary Prospectus and final
term sheet prepared and filed pursuant to Section 5(b)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Applicable Time: 12:00 P.M. New York City Time</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Closing Date, Time and Location: November 10, 2021 at 9:00 a.m.
London time at 1221 Avenue of the Americas, New York, New York 10020</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">I-1</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>SCHEDULE&nbsp;II</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt"><B>Underwriters</B></TD>
    <TD STYLE="vertical-align: top; padding-left: 0pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1px solid; padding-right: 0pt; padding-left: 0pt; text-align: center"><B>Principal Amount of </B><BR> <B>Securities to be Purchased</B></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; width: 56%">Citigroup Global Markets Limited</TD>
    <TD STYLE="padding-left: 0pt; text-align: right; width: 4%">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right; width: 25%">&euro;113,125,000</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">Banco Bilbao Vizcaya Argentaria, S.A.</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">113,125,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">ANZ Securities, Inc.</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">Banco Santander, S.A.</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">Barclays Bank PLC</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">BNP Paribas</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">BNY Mellon Capital Markets, LLC</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">Goldman Sachs &amp; Co. LLC</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">HSBC Bank plc</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">ICBC Standard Bank Plc</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">J.P. Morgan Securities plc</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">Merrill Lynch International</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">Morgan Stanley &amp; Co. International plc</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">U.S. Bancorp Investments, Inc.</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">Wells Fargo Securities International Limited</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">20,750,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">CastleOak Securities, L.P.</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">2,000,000</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(229,255,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">Siebert Williams Shank &amp; Co. LLC</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1px solid; padding-left: 0pt; text-align: right">2,000,000</TD>
    <TD STYLE="border-bottom: Black 1px solid; padding-left: 0pt; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 36pt">Total</TD>
    <TD STYLE="padding-left: 0pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 3px double; padding-left: 0pt; text-align: right">&euro;500,000,000</TD>
    <TD STYLE="border-bottom: Black 3px double; padding-left: 0pt; text-align: right">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">II-1</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>SCHEDULE&nbsp;III</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Schedule of Electronic Road Shows</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Electronic road show dated November 2, 2021</P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">III-1</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>SCHEDULE&nbsp;IV</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Schedule of Permitted Free Writing Prospectuses</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">None</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">IV-1</P>



<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>SCHEDULE&nbsp;V</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B><I>Dated November 3, 2021<BR>
Free Writing Prospectus Filed Pursuant to Rule 433<BR>
Supplementing Prospectus dated October 30, 2020 and<BR>
Prospectus Supplement dated November 3, 2021<BR>
Registration Statement No. 333-249768</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&euro;500,000,000<BR>
Colgate-Palmolive Company<BR>
0.300%Senior Notes due 2029<BR>
<BR>
</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Final Term Sheet</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 18pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 41%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Issuer:</B></FONT></TD>
    <TD STYLE="width: 59%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Colgate-Palmolive Company</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Anticipated Ratings:</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>(Moody&rsquo;s/S&amp;P)*</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><I>[Intentionally omitted]</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Trade Date:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">November 3, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Settlement Date:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">November 10, 2021 (T+5)**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Joint Book-Running Managers:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Citigroup Global Markets Limited</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Banco Bilbao Vizcaya Argentaria, S.A.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Co-Managers:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ANZ Securities, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Banco Santander, S.A.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Barclays Bank PLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BNP Paribas</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BNY Mellon Capital Markets, LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Goldman Sachs &amp; Co. LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">HSBC Securities (USA) Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ICBC Standard Bank Plc</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">J.P. Morgan Securities plc</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Merrill Lynch International</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Morgan Stanley &amp; Co. International plc</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">U.S. Bancorp Investments, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Wells Fargo Securities International Limited</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">CastleOak Securities, L.P.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Siebert Williams Shank &amp; Co. LLC</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>London Paying Agent:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">The Bank of New York Mellon, London Branch</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Stabilization:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Stabilization/FCA</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Security Description:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">SEC-registered 8-year 0.300% Senior Notes (the &ldquo;Notes&rdquo;)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Principal Amount:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&euro;500,000,000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Currency of Payment:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Euro</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Maturity Date:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">November 10, 2029</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Interest Payment Dates:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Payable annually in arrears on November 10 of each year, commencing November 10, 2022</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Day Count Convention:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">ACTUAL/ACTUAL (ICMA)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">V-1</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 41%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Interest Rate:</B></FONT></TD>
    <TD STYLE="width: 59%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">0.300% per annum</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Pricing Benchmark:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">8-year EUR mid-swap</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Pricing Benchmark Yield:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">0.108%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Re-offer Spread vs. Pricing Benchmark:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">MS + 23 bps</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Re-offer Yield (annual):</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">0.338%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Government Benchmark:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">DBR 0.000% due August 15, 2029</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Government Benchmark Price and Yield:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">102.39; -0.303%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Re-offer Spread vs. Government Benchmark:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">B + 64.1 bps</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Price to Public:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">99.701% plus accrued interest, if any, from November 10, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Gross Proceeds:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&euro;498,505,000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Optional Redemption:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At any time prior to August 10, 2029 (the date that is three months
        prior to the maturity date of the Notes) at a discount rate of Comparable Government Bond Rate plus 10 basis points, plus accrued
        and unpaid interest to the redemption date</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At any time on or after August 10, 2029 (the date that is three
        months prior to the maturity date of the Notes) at a redemption price equal to 100% of the principal amount of the Notes being
        redeemed, plus accrued and unpaid interest to, but excluding, the redemption date</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Payment of Additional Amounts:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Yes, subject to the customary exceptions described in the preliminary prospectus supplement dated November 3, 2021 (the &ldquo;Preliminary Prospectus Supplement&rdquo;).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Redemption for Tax Reasons:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Yes, as described in the Preliminary Prospectus Supplement.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Listing:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">The Issuer intends to apply to list the Notes on the New York Stock Exchange.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Minimum Denominations:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&euro;100,000 and integral multiples of &euro;1,000 in excess thereof</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>CUSIP/ISIN/Common Code:</B></FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">194162AL7 / XS2405875480<B> </B>&nbsp;/ 240587548</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>*Note: A securities rating is not a recommendation to buy, sell
or hold securities and may be subject to revision or withdrawal at any time.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">**Under Rule 15c6-1 of the U.S. Securities Exchange Act of 1934,
as amended, trades in the secondary market generally are required to settle in two business days, unless the parties to any such
trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to the second business day prior to
the settlement date will be required, because the Notes initially will settle in T+5, to specify an alternate settlement cycle
at the time of any such trade to prevent a failed settlement. If you wish to trade the Notes prior to the second business day prior
to the settlement date, you should consult your own advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>The issuer has filed a registration statement (including a prospectus)
with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) for the offering to which this communication relates.
Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with
the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR
on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will
arrange to send you the prospectus if you request it by calling Citigroup Global Markets Limited toll-free at 1-800-831-9146 or
Banco Bilbao Vizcaya Argentaria, S.A. collect at +34-91-537-9330.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">V-2</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>MiFID II / UK MiFIR professionals/ECPs-only / No PRIIPs or UK
PRIIPs KID &mdash; Manufacturer target market (MiFID II / UK MiFIR product governance) is eligible counterparties and professional
clients only (all distribution channels). No PRIIPs / UK PRIIPs key information document (KID) has been prepared as the Notes are
not available to retail investors in the European Economic Area or the United Kingdom.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In the United Kingdom, this final term sheet is for distribution
only to persons who (i) have professional experience in matters relating to investments and qualifying as investment professionals
falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the &ldquo;Financial
Promotion Order&rdquo;), (ii) are persons falling within Article 49(2)(a) to (d) (&ldquo;high net worth companies, unincorporated
associations etc.&rdquo;) of the Financial Promotion Order, or (iii) are persons to whom an invitation or inducement to engage
in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000 (as amended, the &ldquo;FSMA&rdquo;))
in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all
such persons together being referred to as &ldquo;relevant persons&rdquo;). In the United Kingdom, this final term sheet is directed
only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment
activity to which this document relates is available in the United Kingdom only to relevant persons and, in the United Kingdom,
will be engaged in only with relevant persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">This final term sheet is only addressed to, and is directed at,
persons and legal entities in the United Kingdom who are &ldquo;qualified investors&rdquo; within the meaning of Article 2(e) of
Regulation (EU) 2017/1129 (as amended) as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal)
Act 2018 (as amended, the &ldquo;EUWA&rdquo;). The securities described in this final term sheet are not intended to be offered,
sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United
Kingdom. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point
(8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law of the United Kingdom by virtue of the EUWA or
(ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement
Directive (EU) 2016/97 (as amended), where that customer would not qualify as a professional client, as defined in point (8) of
Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information
document required by Regulation (EU) No 1286/2014 (as amended) as it forms part of domestic law by virtue of the EUWA (the &ldquo;UK
PRIIPs Regulation&rdquo;) for offering or selling the securities described in this final term sheet or otherwise making them available
to retail investors in the United Kingdom has been prepared and therefore offering or selling such securities or otherwise making
them available to any retail investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">This final term sheet is only addressed to, and is directed at,
persons and legal entities in member states of the European Economic Area who are &ldquo;qualified investors&rdquo; within the
meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended). The securities described in this final term sheet are not intended
to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor
in the European Economic Area. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client
as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &ldquo;MiFID II&rdquo;) or (ii) a customer within
the meaning of Directive (EU) 2016/97 (as amended), where that customer would not qualify as a professional client as defined in
point (10) of Article 4(1) of MiFID II. Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended,
the &ldquo;PRIIPs Regulation&rdquo;) for offering or selling the securities described in this final term sheet or otherwise making
them available to retail investors in the European Economic Area has been prepared and therefore offering or selling such securities
or otherwise making them available to any retail investor in the European Economic Area may be unlawful under the PRIIPs Regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR
BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY
GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">V-3</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: center">Exhibit A-1</P>



<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>c102503_ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 8pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <TD STYLE="width: 70%; font: 10.5pt Arial, Helvetica, Sans-Serif"><IMG SRC="x1_c102503a001.jpg" ALT=""></td>
    <TD STYLE="width: 30%">Hogan Lovells US LLP<br>
    Columbia Square<br>
    555 Thirteenth Street, NW<br>
    Washington, DC 20004<br>
    T&nbsp;&nbsp;+1 202 637 5600<br>
    F&nbsp;&nbsp;+1 202 637 5910<br>
    www.hoganlovells.com</td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">November 5, 2021</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Colgate-Palmolive Company<BR>
300 Park Avenue<BR>
New York, New York, 10022</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">To the addressee referred to above:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We are acting as counsel to Colgate-Palmolive
Company, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), in connection with its proposed sale of &euro;500 million principal
amount of the Company&rsquo;s 0.300% Senior Notes due 2029 (the &ldquo;<B>Securities</B>&rdquo;) pursuant to its registration statement
on Form S-3 (File No. 333-249768) (the &ldquo;<B>Registration Statement</B>&rdquo;) filed by the Company with the Securities and
Exchange Commission under the Securities Act of 1933, as amended (the &ldquo;<B>Act</B>&rdquo;) on October 30, 2020, and the prospectus
dated October 30, 2020 (the &ldquo;<B>Prospectus</B>&rdquo;), as supplemented by the supplement to the Prospectus dated November
3, 2021 (the &ldquo;<B>Prospectus Supplement</B>&rdquo;). The Notes are to be issued pursuant to an Indenture, dated November 15,
1992, between the Company and The Bank of New York Mellon (formerly known as The Bank of New York), as trustee (the &ldquo;<B>Indenture</B>&rdquo;).
This opinion letter is furnished to you at your request to enable you to fulfill the requirements of Item 601(b)(5) of Regulation
S-K, 17 C.F.R. &sect; 229.601(b)(5), in connection with the Registration Statement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">For purposes of this opinion letter, we
have examined copies of such agreements, instruments and documents as we have deemed an appropriate basis on which to render the
opinions hereinafter expressed. In our examination of the aforesaid documents, we have assumed the genuineness of all signatures,
the legal capacity of all natural persons, the accuracy and completeness of all documents submitted to us, the authenticity of
all original documents, and the conformity to authentic original documents of all documents submitted to us as copies (including
pdfs). As to all matters of fact, we have relied on the representations and statements of fact made in the documents so reviewed,
and we have not independently established the facts so relied on. This opinion letter is given, and all statements herein are made,
in the context of the foregoing.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">For purposes of this opinion letter, we
have assumed that (i) The Bank of New York Mellon (formerly known as the Bank of New York), as successor trustee (the &ldquo;<B>Trustee</B>&rdquo;)
under the Indenture, filed as Exhibit 4.1 to the Registration Statement, has all requisite power and authority under all applicable
laws, regulations and governing documents to execute, deliver and perform its obligations under the Indenture and has complied
with all legal requirements pertaining to its status as such status relates to the Trustee&rsquo;s right to enforce the Indenture
against the Company, (ii) the Trustee has duly authorized, executed and delivered the Indenture, (iii) the Trustee is validly existing
and in good standing in all necessary jurisdictions, (iv) the Indenture constitutes a valid and binding obligation,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Hogan Lovells US LLP is a limited liability
partnership registered in the District of Columbia. &ldquo;Hogan Lovells&rdquo; is an international legal practice that includes
Hogan Lovells US LLP and Hogan Lovells International LLP, with offices in: Alicante Amsterdam Baltimore Beijing Birmingham Boston
Brussels Colorado Springs Denver Dubai Dusseldorf Frankfurt Hamburg Hanoi Ho Chi Minh City Hong Kong Houston Johannesburg London
Los Angeles Luxembourg Madrid Mexico City Miami Milan Minneapolis Monterrey Moscow Munich New York Northern Virginia Paris Perth
Philadelphia Rome San Francisco S&atilde;o Paulo Shanghai Silicon Valley Singapore Sydney Tokyo Warsaw Washington, D.C. Associated
Offices: Budapest Jakarta Riyadh Shanghai FTZ Ulaanbaatar. Business Service Centers: Johannesburg Louisville. Legal Services Center:
Berlin. For more information see www.hoganlovells.com</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify">Colgate-Palmolive Company</td>
    <TD STYLE="width: 20%; text-align: center">- 2 -</td>
    <TD STYLE="width: 40%; text-align: right">November 5, 2021</td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">enforceable against the Trustee in accordance
with its terms, (v) there has been no mutual mistake of fact or misunderstanding or fraud, duress or undue influence in connection
with the negotiation, execution or delivery of the Indenture, and the conduct of all parties to the Indenture has complied with
any requirements of good faith, fair dealing and conscionability, (vi) at the time of offer, issuance and sale of any Securities,
the Registration Statement will have been declared effective under the Act and no stop order suspending its effectiveness will
have been issued and remain in effect and (vii) there are and have been no agreements or understandings among the parties, written
or oral, and there is and has been no usage of trade or course of prior dealing among the parties that would, in either case, define,
supplement or qualify the terms of the Indenture. We also have assumed the validity and constitutionality of each relevant statute,
rule, regulation and agency action covered by this opinion letter.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This opinion letter is based as to matters
of law solely on the applicable provisions of the following, as currently in effect: (i) the General Corporation Law of the State
of Delaware, as amended, and (ii) the laws of the State of New York (but not including any laws, statutes, ordinances, administrative
decisions, rules or regulations of any political subdivision below the state level). We express no opinion herein as to any other
laws, statutes, ordinances, rules, or regulations (and in particular, we express no opinion as to any effect that such other laws,
statutes, ordinances, rules, or regulations may have on the opinions expressed herein).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Based upon, subject to and limited by the
foregoing, we are of the opinion that the Securities have been duly authorized on behalf of the Company and that, following (i)
receipt by the Company of the consideration for the Securities specified in the Underwriting Agreement dated November 3, 2021 (as
amended, the &ldquo;<B>Agreement</B>&rdquo;) among the Company and Citigroup Global Markets Limited and Banco Bilbao Vizcaya Argentaria,
S.A. as representatives of the several underwriters named therein and (ii) the due execution, authentication, issuance and delivery
of the Securities pursuant to the terms of the Indenture, the Securities will constitute valid and binding obligations of the Company.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The opinion expressed above with respect
to the valid and binding nature of obligations may be limited by bankruptcy, insolvency, reorganization, receivership, moratorium
or other laws affecting creditors&rsquo; rights (including, without limitation, the effect of statutory and other law regarding
fraudulent conveyances, fraudulent transfers and preferential transfers) and by the exercise of judicial discretion and the application
of principles of equity, good faith, fair dealing, reasonableness, conscionability and materiality (regardless of whether the Securities
are considered in a proceeding in equity or at law).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We note that, with reference to obligations
stated to be payable in a currency other than U.S. dollars, that (i) a New York statute provides that a judgment rendered by a
court of the State of New York in respect of an obligation denominated in any such other currency is to be rendered in such other
currency but is then to be converted into U.S. dollars at the rate of exchange prevailing on the date of entry of the judgment
and (ii) a judgment rendered by a federal court sitting in the State of New York in respect of an obligation denominated in any
such other currency will be expressed in U.S. dollars, but we express no opinion as to the date of the rate of exchange such federal
court will apply. Further with respect to both a New York State court or a federal court, we express no opinion as to any rate
of exchange that might be applied.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This opinion letter has been prepared for
use in connection with the filing by the Company of a Current Report on Form 8-K on the date hereof, which Form 8-K will be incorporated
by reference</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify">Colgate-Palmolive Company</td>
    <TD STYLE="width: 20%; text-align: center">- 3 -</td>
    <TD STYLE="width: 40%; text-align: right">November 5, 2021</td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">into the Registration Statement and speaks
as of the date hereof. We assume no obligation to advise you of any changes in the foregoing subsequent to the delivery of this
opinion letter.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We hereby consent to the filing of this
opinion letter as Exhibit 5.1 to the above-described Form 8-K and to the reference to this firm under the caption &ldquo;Legal
Matters&rdquo; in the Prospectus Supplement constituting a part of the Registration Statement. In giving this consent, we do not
thereby admit that we are an &ldquo;expert&rdquo; within the meaning of the Act.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Very truly yours,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">/s/ Hogan Lovells US LLP</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">HOGAN LOVELLS US LLP</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
<!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>x1_c102503a001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 x1_c102503a001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !? %\# 2(  A$! Q$!_\0
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M?>)-+@O[JXOQX9BT]S:QVDVCM<0^F_&/]ESXY_MR_'O]EWQ;^T3\-O"'P'^
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MG;7^K5X9HPIDBDC#\H71D# ]"I8 $>XJ.OPR_8U^/O[*?[2_Q#^ /BC]B/\
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;LN2G34I1@J::ITH0IQ]U7DU'FG)N4FW:W__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cl-20211105.xsd
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Nov 05 17:50:38 UTC 2021 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:cl="http://www.colgate.com/20211105" targetNamespace="http://www.colgate.com/20211105" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cl-20211105_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cl-20211105_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cl-20211105_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+zoEiIZmtp2H7C6qvFYFNeA86aF0ybghYRPDx9gBHG4hrnGiYZKGPUxrjymER5RbLDXbQsGvqMYlkK78awuTh6oFF0/i9MwfwFm0kQaXDPI4HKjtQnZXddYRN/Ji31S6d4X9j5m2q0DLvwkb8LYW4OhBu72OTymXX+Qg3EZBrG1Qae91gPuv5isk78af72UeY57vwyhzIjpfuVOmAqnJv9YB2fH96alps=] CSR-->
      <link:roleType roleURI="http://www.colgate.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <xs:element name="CommonStock100ParValueMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cl_CommonStock100ParValueMember"/>
  <xs:element name="One375NotesDue2034Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cl_One375NotesDue2034Member"/>
  <xs:element name="Zero500NotesDue2026Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cl_Zero500NotesDue2026Member"/>
  <xs:element name="Zero875NotesDue2039Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cl_Zero875NotesDue2039Member"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cl_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>cl-20211105_def.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Nov 05 17:50:38 UTC 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="cl-20211105.xsd#DocumentAndEntityInformation" roleURI="http://www.colgate.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.colgate.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cl_CommonStock100ParValueMember" xlink:href="cl-20211105.xsd#cl_CommonStock100ParValueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="cl_CommonStock100ParValueMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cl_Zero500NotesDue2026Member" xlink:href="cl-20211105.xsd#cl_Zero500NotesDue2026Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="cl_Zero500NotesDue2026Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cl_One375NotesDue2034Member" xlink:href="cl-20211105.xsd#cl_One375NotesDue2034Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="cl_One375NotesDue2034Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cl_Zero875NotesDue2039Member" xlink:href="cl-20211105.xsd#cl_Zero875NotesDue2039Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="cl_Zero875NotesDue2039Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+zoEiIZmtp2H7C6qvFYFNeA86aF0ybghYRPDx9gBHG4hrnGiYZKGPUxrjymER5RbLDXbQsGvqMYlkK78awuTh6oFF0/i9MwfwFm0kQaXDPI4HKjtQnZXddYRN/Ji31S6d4X9j5m2q0DLvwkb8LYW4OhBu72OTymXX+Qg3EZBrG1Qae91gPuv5isk78af72UeY57vwyhzIjpStl99pZYxD5uaBiQ7MbOcs=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="22" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>cl-20211105_lab.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Nov 05 17:50:38 UTC 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="cl_CommonStock100ParValueMember" xlink:href="cl-20211105.xsd#cl_CommonStock100ParValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cl_CommonStock100ParValueMember_lbl" xml:lang="en-US">Common Stock100 Par Value Member</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+zoEiIZmtp2H7C6qvFYFNeA86aF0ybghYRPDx9gBHG4hrnGiYZKGPUxrjymER5RbLDXbQsGvqMYlkK78awuTh6oFF0/i9MwfwFm0kQaXDPI4HKjtQnZXddYRN/Ji31S6d4X9j5m2q0DLvwkb8LYW4OhBu72OTymXX+Qg3EZBrG1Qae91gPuv5isk78af72UeY57vwyhzIjpVRbxO3dNZbNTCKFVEAHmW8=] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cl_CommonStock100ParValueMember" xlink:to="cl_CommonStock100ParValueMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cl_Zero500NotesDue2026Member" xlink:href="cl-20211105.xsd#cl_Zero500NotesDue2026Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cl_Zero500NotesDue2026Member_lbl" xml:lang="en-US">Zero500 Notes Due2026 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cl_Zero500NotesDue2026Member" xlink:to="cl_Zero500NotesDue2026Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cl_One375NotesDue2034Member" xlink:href="cl-20211105.xsd#cl_One375NotesDue2034Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cl_One375NotesDue2034Member_lbl" xml:lang="en-US">One375 Notes Due2034 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cl_One375NotesDue2034Member" xlink:to="cl_One375NotesDue2034Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cl_Zero875NotesDue2039Member" xlink:href="cl-20211105.xsd#cl_Zero875NotesDue2039Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cl_Zero875NotesDue2039Member_lbl" xml:lang="en-US">Zero875 Notes Due2039 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cl_Zero875NotesDue2039Member" xlink:to="cl_Zero875NotesDue2039Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cl_Zero500NotesDue2026Member_lbl0" xml:lang="en-US">Zero500NotesDue2026Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cl_Zero500NotesDue2026Member" xlink:to="cl_Zero500NotesDue2026Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cl_Zero875NotesDue2039Member_lbl0" xml:lang="en-US">Zero875NotesDue2039Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cl_Zero875NotesDue2039Member" xlink:to="cl_Zero875NotesDue2039Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cl_CommonStock100ParValueMember_lbl0" xml:lang="en-US">CommonStock100ParValueMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cl_CommonStock100ParValueMember" xlink:to="cl_CommonStock100ParValueMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cl_One375NotesDue2034Member_lbl0" xml:lang="en-US">One375NotesDue2034Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cl_One375NotesDue2034Member" xlink:to="cl_One375NotesDue2034Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl0" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl0" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>cl-20211105_pre.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Nov 05 17:50:38 UTC 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cl-20211105.xsd#DocumentAndEntityInformation" roleURI="http://www.colgate.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.colgate.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="cl-20211105.xsd#cl_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CommonStock100ParValueMember" xlink:href="cl-20211105.xsd#cl_CommonStock100ParValueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="CommonStock100ParValueMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Zero500NotesDue2026Member" xlink:href="cl-20211105.xsd#cl_Zero500NotesDue2026Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="Zero500NotesDue2026Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="One375NotesDue2034Member" xlink:href="cl-20211105.xsd#cl_One375NotesDue2034Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="One375NotesDue2034Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Zero875NotesDue2039Member" xlink:href="cl-20211105.xsd#cl_Zero875NotesDue2039Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="Zero875NotesDue2039Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+zoEiIZmtp2H7C6qvFYFNeA86aF0ybghYRPDx9gBHG4hrnGiYZKGPUxrjymER5RbLDXbQsGvqMYlkK78awuTh6oFF0/i9MwfwFm0kQaXDPI4HKjtQnZXddYRN/Ji31S6d4X9j5m2q0DLvwkb8LYW4OhBu72OTymXX+Qg3EZBrG1Qae91gPuv5isk78af72UebHT8nZ8mqJx988BZgmkg+jv1F8ZRPXSLg=] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>c102503_8k-ixbrl_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cl="http://www.colgate.com/20211105"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cl-20211105.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021665</identifier>
        </entity>
        <period>
            <startDate>2021-11-05</startDate>
            <endDate>2021-11-05</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021665</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cl:CommonStock100ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-05</startDate>
            <endDate>2021-11-05</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021665</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cl:Zero500NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-05</startDate>
            <endDate>2021-11-05</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021665</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cl:One375NotesDue2034Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-05</startDate>
            <endDate>2021-11-05</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021665</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cl:Zero875NotesDue2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-05</startDate>
            <endDate>2021-11-05</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="c0">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c0">2021-11-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c0">COLGATE-PALMOLIVE COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c0">1-644</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c0">13-1815595</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">300 Park Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">10022</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">310-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c1">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c1">CL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c1">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c2">0.500% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2">CL26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c3">1.375% Notes due 2034</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c3">CL34</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c3">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c4">0.875% Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c4">CL39</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c4">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c0">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0">0000021665</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140273860541912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COLGATE-PALMOLIVE
COMPANY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000021665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  03,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-1815595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Park Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">310-2000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cl_CommonStock100ParValueMember', window );">Common Stock100 Par Value Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cl_Zero500NotesDue2026Member', window );">Zero500 Notes Due2026 Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CL26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.500% Notes due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cl_One375NotesDue2034Member', window );">One375 Notes Due2034 Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CL34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.375% Notes due 2034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cl_Zero875NotesDue2039Member', window );">Zero875 Notes Due2039 Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CL39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.875% Notes due 2039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cl_CommonStock100ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cl_CommonStock100ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cl_Zero500NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cl_Zero500NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cl_One375NotesDue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cl_One375NotesDue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cl_Zero875NotesDue2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cl_Zero875NotesDue2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    "  3@F53EXJ[',
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MA1H#V#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ $X)E4P=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  3@F53
M)=($J^X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    "  3@F53F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !."95.#QQYM)@4
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M2P$"% ,4    "  3@F53)!Z;HJT   #X 0  &@              @ &;$@
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  3@F5399!Y
MDAD!  #/ P  $P              @ & $P  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #*%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>5</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="c102503_8k-ixbrl.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.colgate.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="c102503_8k-ixbrl.htm">c102503_8k-ixbrl.htm</File>
    <File>c102503_ex1-1.htm</File>
    <File>c102503_ex5-1.htm</File>
    <File>cl-20211105.xsd</File>
    <File>cl-20211105_def.xml</File>
    <File>cl-20211105_lab.xml</File>
    <File>cl-20211105_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "c102503_8k-ixbrl.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 5,
   "dts": {
    "definitionLink": {
     "local": [
      "cl-20211105_def.xml"
     ]
    },
    "inline": {
     "local": [
      "c102503_8k-ixbrl.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cl-20211105_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cl-20211105_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cl-20211105.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd"
     ]
    }
   },
   "elementCount": 31,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 4,
   "memberStandard": 0,
   "nsprefix": "cl",
   "nsuri": "http://www.colgate.com/20211105",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "c102503_8k-ixbrl.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.colgate.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "c102503_8k-ixbrl.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 4,
   "tag": {
    "cl_CommonStock100ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonStock100ParValueMember",
        "terseLabel": "Common Stock100 Par Value Member"
       }
      }
     },
     "localname": "CommonStock100ParValueMember",
     "nsuri": "http://www.colgate.com/20211105",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cl_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.colgate.com/20211105",
     "xbrltype": "stringItemType"
    },
    "cl_One375NotesDue2034Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "One375NotesDue2034Member",
        "terseLabel": "One375 Notes Due2034 Member"
       }
      }
     },
     "localname": "One375NotesDue2034Member",
     "nsuri": "http://www.colgate.com/20211105",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cl_Zero500NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Zero500NotesDue2026Member",
        "terseLabel": "Zero500 Notes Due2026 Member"
       }
      }
     },
     "localname": "Zero500NotesDue2026Member",
     "nsuri": "http://www.colgate.com/20211105",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cl_Zero875NotesDue2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Zero875NotesDue2039Member",
        "terseLabel": "Zero875 Notes Due2039 Member"
       }
      }
     },
     "localname": "Zero875NotesDue2039Member",
     "nsuri": "http://www.colgate.com/20211105",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.colgate.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000930413-21-001845-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000930413-21-001845-xbrl.zip
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M1E4<1S IH[^. 865+N=-DYQ3\9U48*;79[,!96/Y)9RI3JKPSS/1] <>S-Q
MUM>^^/Y4N%64.!/GD.IQ7%\OXP1E-@Y.1\FWE$I$HSSW(:%UO_+@*;-3,*M<
M[A=3B.*OIA"WF=R+Q,R(FSA+/!>@+CP ?U@;,KN/J,A9&WPODRN- 6L@9()2
M?K#K?QUK5.9C)\VXPCY#P*;BVWB-XA]_V\Y96[LR%3*7!5W?8\13T7L#)OFV
MV\< 1&#:A5M>#KMW56IL<^BH*O">MK*<E9M;5UK>2QW[H/[G2%R<_><MT\B9
MIOGPQ9-',_7Q:U7/2,)\YP_=ZCFN'38?O-%3F-OHV9[T:LMOX+Q+J4UU5^TR
M8!A,PP@- N$'@N/4K.4/28NY_H!PM:R?.L22E&WC"VES%TV02[#'D $F!S<$
M)._UW9!ZS.]+=T0D^$;9'BFTT0M^"P:NDU^]4S"QF*=#,:'>*&YK0_[G#_ ]
M7.CA.".3*3#VLF28NI2CXAD79AJ HJ]FCJ22R64TU>NE%^/?DZ3-RR7#NV1,
M^MTT_UK:7/AM4<R;M+;E@N#R&P5M/F2.T:8N%K",_>M?@H>@6S@;[WO1E$E&
MT148OK-5*.PNF]4\P8 B<F DD_208&)##%T'*>2*D2:C"D_L0N'FTYJU1:J'
M%R27-S, N/Z8"?PCY3.;I)1(\7Z%BO7\CO3I=9"U&IX^6N<;$*YLZ,/KG( #
M!B_LKD[AQ[2 []/$S&N[5:"&E9M0^'BO=5K="V9&0WYH_(?&3VG\N6#HX1E,
M[55%""83 N9IR;K)"C0?:#+L":+N]?E6P3%R:ZWUY>Q PWY8PH<EW&4)=2G[
M3+Q1>\@SH[!F+V</$>SZ0]<]GCEU?Z;N)A)"/?5A B9/P7195021LI13B69#
MP+@W-J%9=J+RL'V *>U>8-H)MGS^M^EE@=9L_6?4&)=-S;4_T7I@J]S$.FVB
M2JWL+K%=*J6NLIDQUN<=3B2RJ&HLLZ76L..'495K_/CIABZH6JYKC'HMWUW#
MQ=<E!J[',!Y[X4V._32J6%)29[$'W&N);#GE>V30Y?!\[ 82SMP;P?0PIX/8
M"D9X1\RSIJ8UVJ6-K%Q+64*ZC)$..- (??O[!OF[E3%-H%60&^K.;TO-:<LK
M'FJD[EK;89S';V\PLZ56J+CS55:Q3./ KNL*X]T_+=DDZB]DPCO0\MS=6@X8
M(**14S^$X.?T&9:R;KXQA<C=J=UO<3@?^KTTM_)WZ[>5R6\5I_4;*^O?E$+D
M[]3OMSB<5ZW?KS!/NX.;A?O\^_:<_N_<JS!OF 7S]O$.A_O"]O-^USKJGH-K
M1 RO-K#5#G,/:\\&7:8*?J>W?U-<$NH1!@SJX'RQ(_Q!V,6EI@"WA"D8&&MS
M3Y_ST#MM9C%>&YG99M-GO/+).A..>VM7;;J9Q74L.=;+5+F6D8M0I!:<%YO
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M_W?FL?Q6<2SK?.$^6;]O41?>KZC1KK>G9+WSOV37V<E<4O],,G6 CW/[K/Z
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MDJ0- >ER%S\KQT;BF6PL,H0R5ZA^RQ@O58X!P!EHL/!,O$[];N4DT[+6<?U
M(@08)@K!RKYNG&QX898D6"%/7Y!+06>D,GW831-0<H&R= $'V%7,O287K#I3
MH##!5,Q _\(K4UP;<HNM>HB:""20!+0QL&&,JD\)A>";Y!. #A)#S*H2=YC^
M+E"[9(@25PPF(#1'@6Z\="XPY<J4IPIFK$V(=$:IM.!@^C9Z9;]7@Z_T/<$4
MW@6#$4%J[*KI(W[+X"Q*6Q!"5,GC-80)'$DJTK(UK"4F:S>L!<!C$Q5&"*M(
M/UR;B/@8U<8BSYFIQ]BK5XON]V35ZPUY_*,D%@:2.T66]P,DEN05YHLL[TXD
MUEOC\=0,/U>"J+UANZZK.EQT(#M8W%BJ<P&+!'AT]=^=&E\_VHSZU\W<<$9<
MF=,]W0&*144@7&U0NX*KWV'G-#86YM:-56-;8";7U701D,>JR<3I][;<V\*S
M,D<JB^0$^^Q^"\IN\=(8CKA*2M%/&#(:T:\OXBS1KY,@-+V5D;1R]U.4JVL$
M21B- WRN=C=F!B&9CGAYQC6GF&+!9Z-, L&09!BW-!Y"+N<_:,R^F!.)?+Z*
M1"XC$OE\%8E\>)'(%H]V45\7L1N,FD?=HFNK.U)23KZ%2J,P&ST3H_&Z=P^S
M*N7V5OUJ2_)(8(T?4A11V? ,YS]=3!&!(M2"T+>$G@@ML- HF+98(.V.4CFI
M:A#C$L&1-(.+L/;6!HS'Y,CI-A4#S\1P) 452:<=V&$Q7-WN[(D=%=;5M7/(
MB2T^NPLM@+I4P'I'K: >F)-*P*8T5D"JCU%=/\K D:/WNVX'6_K(6UE(^"!H
M8[E1OXL:2N3\;S#<%>=.X)98I-\SWQ9+?R0%#'\X=Q"LC/59',](&=V+N[RG
M2/8@\>O^@2*V QB3>TZ@F5[FM.K1^:ARTK_V'H"-X&Y";-4IJKC[E6:47.<8
M-37#J<W&L0T:B?$XD<>LYH3K^+E\#Y&J,+0J:L0J7#(5#3I1+H.#"%9=Y=S*
M..TDUEOF<KF/.V:X#)>" 85#IUVP8KR3;S/R?^X2L_1AQ$>_7<.P_X)V(S59
M+C$1[K-YK292D)-</R26!P@G=QJQ_WP[;:KK6:0N3#3AHOJ/I@G@I34E2!&J
M/!N2YTO9**5?D&@BT-S:3 8*(##?>&S'D.1R+AIK+HMD6'U=OLA2C#%<Q&%%
M$0=3]1&<G:$+CB79RQ"VI%*NK8O?<HN_CC87];R%KFS!4O D"L^H_8RECL4*
M2&QD1\0&C%(NQW/XL"O,ID6FOG,H.(QW)Q'^#J\]N6&IZJG,3#';"GH! T@C
M;#_LFLQA!G@TBXF(3YTGND=3D%B,Y-"X+S;J>6<A64=EM]0L8I(WGX<(4$HY
M+'\6)IACUO7"S732+':FQ$10G'OC)&N8>5;9MA3/I4:3PS/B+"SH>')R1\$5
M</)Z;FQ*.F+H')N0,L8*JY1B<]? Y:C]VH)4EI2IRE+IJF",9]1K3"78A\L?
MH6& 0LLLQPK\22TI]D:X9,!:,(20%L,"::<KKM+,0IE88C7Y/3B9DVN<S",X
M=]$E,@/0KXCV,N1$8 9PWU'K9+Q9(_9)@&#X$W8;MQ[4ZQY-GU.?L'I4NXSN
MA6<-H[/8(35,$ :*]YQ@0(-FGTU]"LP"_-<.RA*$V;0TSSVBMYMBGX%AO2^H
MS*C/>3?#3IPU)^VQKK,A1WN#+[MZ5M9CXK#T=H53;44L5*2$@<JL**CF!O4M
MFC4CKK@A=QJ[MMCXX7P%)Y9*=A3X!TD9^![L7@0^1($)5YSTP_G543:=21IT
MS1H6E6/7#=CR>23ZAL.85<H/Y;S/T\S\1I(/&8BAJ*2"&C(/QCRNSH4L\[UB
M!DQ-@5A@:[0Q0C!2L7&/7@R4_X;)ERB_@#5[]$^6I;0LG-NWT.BA%ZLXZC+B
MJ"]6<=2?*HXJAAQVBZ!QG\VT$IA(ZTLJ71W:0E*5@=1\<RG6F[EM3BD@=FIF
M-5F'/Z*:%2@T29)B;E]DWW6+!6\8Q:I;HK4@)T>QK)F(2IRG<_SB<U+9HRB^
MB+A+"KX"A1PE/,?8_:AKRU XNODNC!M3Y81(;+R('*G6>@]9KNF2$K\7NR3:
M_53RB2T_FP@ .J=*Q\%%EI.,#Z-1S C&8#90=42.) VI09HWQG;#6]H5?H#3
MNPHU9;>S2+@%E5F<^MY49)32Q'."HX%.YCK! >4)B2ME!]Q3ZH:D.(,">>.^
MO"L+KSN"7"9;/*0:;%4+@V9/44J5ISTXV.HZ[_>L)F(.Q^J;C.4K((?/-COG
M2K;?]BAMW^FM.0U(;YJO3#&"KCZP_.]F>N@DR(<!Z)XG7[XGD=Z<[<W-;:XS
MAOM;_1LR/-LF(:%<G$BSJJI<LEY;+KN1\1YLX;]O.34!'&!T@C'DRY8]JS/8
M4NQZMH(4*!/R+$&=.,;![)*GE=)7VZ'!PK$\X+;BH&2T0#N;0M%(78364L4%
M) G.9#23!#A5M13LL %5=E(H;P7ZK_8FU-@HV:EK0X.!$4SJE*:S2.!&R[76
M:$!+V_#"(1VI]U*4Y@QROZ=B 6PBO56X)R-<(9D!G&B&,S;54V0( &A)!'LK
MHW7*<YM&SJ(H&F?609(WMX<B6 T4=%%0VGQ 7(39+C[-4W8Q":9-!IC$JE6R
MM>8U'DM[N@P47+M0R([PW$"WW09(D?]O]_C01$<9XK"CUWW^S$H5.FV=D*04
MEXM23,SABCZQ9_009-D4"@-1PS;)-=\5:OCTLRK&2LH4^<:(SI)A!!SP%OU0
M?5CEA'(JVK Q8_7@+JVI[FYJ9XT;G;O]WM9.\&3K^=JX%;)GG9 N+' @$N0?
MX$S1./B=+1]D]_:FIE(-'\.7&T[PL/ =FW0'W$<M8%0AZYB=E^!TBF^"?&RU
M_^#*40:-!"Q?2A$QC4DA#V5=FB3[PF1Z5.HA7Y9Z$.,H-":;5@A(<!,)4H;9
M5<SF":]%ZRU3[&CP]KKL*#=<7*UH--NT#C'@QC59?[/<67B(N: 0A-R8(:Z8
M^ZKA!%W"CI%[+!\G5<KIBEHF4A]6(ZG)_+1D(DJ]!,<\(30/.O#*6RL$)<E*
M7(2>V0=)$G:?+4:_N7+?&D4X!&FI3_NC.A7%[4Z%PEP@W>4#;4%_ELHM5__B
MRE.IGK(9F3)<P%SL<%NEJ^H/$XK':SZGSI'H.^H;&HZ8>2-&,+,J:/TNME15
MK)@G\M&B0<W^'UV, W2,IU6]BDJ"&E20P^YA/>%/RQ@'(S03>%1")%XE+:K5
MOURHD__E*NZ[C+CORU7<]^'%?44XE7>0D$+K"OVP%E-5W5/SUJ4HS/?&48B.
MA*\1ED,OR;"^@2HW&YYY'2 0%$P9Z<;H\PJ(XYU'04)OQE#4."JIV0B5+4^?
M*[BI><KJJL2\[7] _V4R6S;[#JZ,3/X988Y22@:B]"+.LY0;&C(7IG'N$QCC
MOJ!AX=,L22I.T$J13(!N /Y;I4+WS7N "H= !=.=)9W>%U2EIR/%H>2&6R,D
M[-U923ZK\T"5"QJ]SU)U(N+>VJ_FJEA5""X"V\ 67I$5]K<;LC7"CBQ>@6.9
M4+=HM8I]RVE62I(0ODN\1M7V#5JBL:I:.H%LDS1+G]0IT_P<WX8@D/49NG13
MD?"U5=4E@B7H=>I4A']E%9A_JVQ%OW>[DFS/%'TX0Y(ZR@F;8573X&,C^<-3
M<0K A=E6C09+]FX#X'\#;8NVA70$<YLOQ>KR^5D726&X61<JL,'<L6!OR$G4
MS)?,B+6Q'8XBC5B[J/P08QCAV_+H'-@CQ@/JLM@QWP\[C9?!-9+NQF\XU"RC
MX\>OG/AQY[2S0 &\%9FLWS ==CS<)=?=,D>VPD18JZZMB3\S<W/V<Y&<8FK-
MG--%G"W9RIEX&7AYAO%7:FT[XYY8SO1&OG+M")0Y&".HJY1XLSYQ4)-=M,!K
ME 9+J(8SO78 3]A7SSI P-<+-4#-.$/=#I. 8-;<HL!J]!A*BP!_B6;9CU+!
MOI?EV.<+ @=?-<+J8WUB7[Y4AL+7C=\WO%U,3N5\HK<WMS9E!+,NLS='FR)/
MDS@)\D:#NO0G$G'!W(@N,#1EMX7XW%-TKJ9G.4TG]C2OMZU8D$20QE >W 6&
MUBU4K+3H0L/!5(DUXH]@?^E-- \WL&YD#+K"1%^O8K<ZVS1?=![1S$;B0/-2
MW,"WC2!AJ]E*XB]6G,"FE(ZC@ZD6CU0'LQ7'L'UMD./4:FR9%T1S'KK=53^Z
MX7W.G-E&*L>I_JW1CM6$1 04[N9KK AM-"MU\JQW1RS;[RW(L]YB+/NH(D(7
M-W.Z.K5GMQOF5@V+?8Z\71(SEO1-;>+4LZ0I<R[BBM1+M-N\#".U)ED:84</
M;2#9)=P@9U(;[06E5HY5003+I' 2<(K9FED-ZE#1.0U?@$M EH3@5DEY+%XC
MR 9Z\E-;^YU&&.8N%(=I^[VU$2H^<F[4B$,Q$S_11Q^:C[9]-M7/IG134<6E
M-)DK+ 4&UY4)H+I+L*M!S;= 2E2OFFC4(!_&)2%,6.">"VK>>H8,;ZM_6+^'
M7\8I0P$SRMWVD6X3P_1X+!2G>[6*TRTC3O=J%:=[L'&ZRX54!F+^7*_,<)DN
M@2I$%*_ LYR"A6U^BAMR[(0Q9]3#X!?/-__!V.[H$EQ:R/2F?V[(_=SH.33]
M#GAJ&NDG&'^X8)U0<F&:AK1BN"JTL*Q*1YVJ (VGVA\<Y=+OV=J%S"D'_&G-
MA<N?IYKPYB]$:WRK,N$&7/VPIQ++8['93C:\#UA;4DI,4@VKC *P2D5'U:ZB
M))YJS,6_[X+]&E3</1]619FS:7%2R\NT/ ;K#R)8N$RKX&\&=A3%K)^PEU7I
M*$[XJOT*=6N0XN691G51!/L=:!1F$R="J4P+B_Q:_]5TLNCC$W6EF56#D6#+
MKVM<"N\^XC^IL(X&!;7N\TUHJ'%C+48+[(A1[)*M9<* $EL&="PU/C"D$I7#
M<$L$,$2.@$YBB,B1N#S/BL@R!.CW->X<V8$G3W^^MZ;+M7UOKQH&X"T=Y"B4
M/E-@[7=@KP!$TPPL/.,OY2"P JI>H8D0<^@+W[Y'RX^C!MG:2<67S\P,C"R7
MR# /P>YR<%!,<66RC#>H>4QQH5TFCL%&:2C1BGA862$*:F>CX8P!PL:QVV*W
ML[9XO+[WKPQ<0N]"FMSQ#*1<#,A,:L2*EBHS4^&<II&3D+4JH$W@0:JI9];F
M#6<"/>3>1 5*$Q-Z&UNW!&=82E%J3*+FJFJBR%Q#6R$7Z1$[I2!]V2ZIK\'"
M JE5X/D/:'+C<*6<>XBP2]6A^MT6MCZ,>-_W:SB!/$)UT;:!*$7,J5!Q71@%
M"35FHUBQ"Q85-)9J@Q6$45)Q7D.F<71)W4,<VSS,&G'8.))HZXLGZ=/2:?3*
M@N8 AZ0QWI,$*2>9^.OP/<OZ,&^1[^*8.XV&"9R#S ZP<IHL':6/XC+#;6ZP
M=]%PVZ.*GLR6G[)6J(G.D*1H=)Z"?#B;Z8)35&?_KN(IEV[BQH,Z0;:6-D4?
M>Q0N,VI*/ _RD*'FBVQ<TD]8Y31$I&L&9TD,W I"6@9E,"1D]78[YN 4=#.]
MQ003,$(0PHIDC)AO52-RZ$?C97=&<.S&X(Z>K7IYHT&87R@*51A#FKP#CD#5
M1@-VQV-5A7TM((L=U6QRJHR<+M13)6>^#MKZ5L36%P,P&$=G%>R1&\(U==,<
MYBTCG<ZV.@_:NU6UU83%GV=HDK+5$:<5U0(H,OJ8K@]!$@0$Z(J+L>QK#,N9
MO=:LX2AK3N3C]X*9I'["8FU:U3A&,F!;;(IVP06G:LR2T4>1H%FD'JX:K^59
MW@?XK>*S=9Y@U\X=0!B3W-> L7ED11U!QC'T&(T*J$J0W@7IDBJU$&0K&7^'
MRH#*TKDRHT8*9X%VJMIT^BV6YT04R*Y$I^YCL@.N>6NNTTUB7LW3#$2CVR:O
MT=#"T&6Y&T/%:Q28<B$@6(7?$5:U4<>(S#I V,0@,W%X=$&TC^6;PF8G(4)'
M3M5I6)#FS?J<^")H,CUX(G.V6?4T- M\R%:?>RLUB-7YS!<.\W%RNJF*E2;"
M10*2KU<!R64$)%^O I(/+R!YB\Y6GLHX4EKPYM)[3I7*PL*[#C;X$[0"UQ;V
M<AOY?X ZP8+.%&-(4F,2ZVUX'BZ:NTCG^CQ*CEBD191H5\P:$EET&IPJX=VH
MZL8$?\!)<)D.&M3])\)M"W)P!\M9K>W"%Z<*6(=>/\K4L!?X'XRPH'>)43YK
MD7?&%4S\N]U@=ICV"?5UW"0_L)B*^*/I1N.YV3HF>Q$!L/504)?*A4UF- *<
M8;'8X'B6!]/S@KKHJ.+S<ET'Y_3L>+*&J,NP0!@J@L'J]WAT94MM6TG!3ZO#
MUDB-UC :AZ4IW&PA&7EK^WOKWO;VRZVG6Z]?O\ 1%81F8$PM7X* %F K%PRC
MI5_H4HTP@VTHXY$JSFF)7 \1-C8O*YT J06\U_X$E@_SX#)(UE6AQ2N>W*RK
M*ZS4\O[7/P?&*!=<'<8V*[)1K/OG+:N1P0RY?MJW9AO4 &DEO:YJ+Q]6N*#U
M8+W[^.7SJ:-N*4*$6_@&= 3H!H2X_>7]]L;-P/C4-^!KWK_[^OZHRD?G02'%
MKR=!$KU[^O7]!DX.^Y>51&=8>3EBC&<G@]IH$]C\URKLBD,G^ FZ.):8Q0IT
MT(&FT<81UGHTA9MO$AOV\%Z^$1W("]5TG/(YH]AWPI)R*E_,-K8M9H$& BBG
M+N$N'Z>*]T1P";T#&5OM*P\!6YE1KT\P]-:"'&$AG$Y)F4MEM_4)J@.NW\,Z
M6/=UZGT/6K)?C\EWEL3D'V3L"C/Y$8^Z(3Y_^+1<"VX(RVF%& FAQ.5Y:FJ'
MTV?Q+_>&JNNHR%R-]%)'6E7Z38-89X+KQE4-?38H^[W7;S8WO<'&IPT]Z@=C
MPICV]CZ#K4.MFENZ53.C62UT=&1*,@:0L1H)C,](E7L7 ?_2NHZF*@5N#%\/
M>ZDO$ZL%2: XL"=[248SF,%)CW0\$\''04'2_)%+A&]B;J:D&J\CA(?AQ.;"
M-^U$^J(R^([VBYE$U6I<=L#12,,NCC6RB6XL1\ZFT2_U]"'*)YPEV1##-\:$
M[O?L3SW6R(S>KWRI!51O$L7T:F=8DH%T5%X0"3-X*8:99,J3IX<\?8A(&&9X
M/-<^9PA6C/U*ASP%C&S?E'_K*XW#C<;8F"1]#?(>BAEKGI1?6D._LO85\)@I
M;XUYK]_C.5/K]&JL#X"_R2(QE^&P0_VOFB?P_*#5-$JB(.=7G@R>?O[#-$BI
M/SHU=GOX&S!VHF "ZX"[D-E.-@8;^C[K"HVV0Y\U=[_TR>0<C4H;TS*!/Z;"
M;>U'%H<=X'"D4DTDW]K& WM$!U9341]9)]2.G.]D>^P3M#SQ2_]]W?#Y?Z 8
M'MY*# _XF.I1GKID9>ZN^JT"EJL0U!A9B]R^ASZ*6-.2<C32V&5D2EF2R786
M&;QAUIP- /'FJQSLJZ9FJ0DQ[!'"$%@!$NP1\<2B9LZS)9DY7R3^0,,7;(]Y
M9>K@?P]*PM*II[))N;+'X(89,+Z.GCNB$8S'S1D2R,BDE56,7^"+6]K^3&_?
M0G7#6YNK./TRXO1;FZM _?T-U-^%'L688;]G!P5T+$(RCQ)<@)/_AHMV2XU4
M0J<<34XX!V&]VLXQFX+4&ME'M_D<K+!OPK*%;^Y=LYKISBTB)5Q@ZLU$9+@A
M.<%MD\52[-$!TL&(=4#I;G8([#^RUTO+K=^H[VNY#8$E85%QJ7%08JR!B)0%
M8.J9+-Q) ARC&KT.R$D51-W>TBU>.L-QPGC8O%&?@OP;%J]P>!',S36[D]BR
MP3^>?+*BB[HG'U1@7+K.E#7Q@&<@*0$N*_F<E8R3-8KS4351P ?HU](T%K/V
MM2V-_86OMR*Z&,.L3UAY:\ #0 /Q%DKUE3-WFR8W+ 8*R6]MXL$AS<^\$.O%
M-0$XF9VIV'2_I[[3YQ"8P^ANRXW+A!M8RZT"9*@:BT9L?!O.KR\1<#QWN&BU
M435&UW7-R!TT3(<;;W$& 9;"PB>L2<V[)O8X0_ G6,V;!VDE+GVZO/W? *MC
MB,*C)*9"K\"!$YM2_>_:*R+F (MC@;.V\1].DN'K.O9U;F]NO7SZ_,7SJS,(
M=JZ (RD8[G_K604)=TNV'[Q'-]TDV)Y1!7P_B7*[<;&&QMMQTG4[85NS*>DF
M ^! -\!1UQ5H$@41%+A^[P,B.F)%.6[X!RI/1[=PS647<Z)'.-4<CMVZK^'-
ML7Q4?XR6?3R,;<;H$_ E8S[_01M'4@U1.TN*<&WARA>;FT^!,Y]=CRL]Q91+
M=BU_%$>VVTFC'V8GW5L326<E]T''9Q/8^@&8Z0MIJ='Z2H,T_DO&P:)ZV[L'
M:ON'ZH27VUU4'RQ5;[>K[:TM1T@^$R'Y*?YX\,$[.%B^ONW\W!]+V]W;TG8!
MI:MUH]>N&F^K]\ !:]W2S2NV%$3H ][3.["A.@24HI@KF8QE@R;#TQ?/G^Y_
M=<89J++WY@.O8HB:ZV+94&BHP.M>/'W]TG[78[(\%HUJ/U]25%L/$.8PMMM2
M)F:*R9*V!7(IV/.@PM]7'*";QL&/,!%'F1U5TZ.FQM8A>QJ)9M_)^&C##H&?
MZZAX=N*J,403WV^!YMDCV9PXN6JN:\>87U<1EEW,*UEW56E"DP&LM:+I.J[R
ME"'E9UF%+10X%8X"^/!OM'TO8M@7G:?$]G]J+@U;OE0UVDX)(+L3#5"-$X87
MV"C%&955 1?7"JS,$".TP3%*W4)Q"=4YA/(%Z(4#>_!Z3IJSP[A0LF%KE6Q8
M2K)A:Y5LN+_)ACE= ;^\;Z)X2CP<#SU/\M!5Y#*M IU+'!:E#[ =KE5UQ!3&
MP.*]9]O/UH;KM@E*-4L\N)8:JW@,E-N)16<>A_A,J>F*6M.CUI0_)C+ 1JTG
M&[4<:,$I!6^<2M)-OYOY6*_C6TEU6!\D,!'X9M^J\KB>7G&UAZ[(;],>JHR^
MOF8"G@+I9R'Q^P+)(,UCV"N*T$ZF/$I]&Z'N%=B>-AYSU=M5VLR9@R(W,%%>
M8/B[8^V^:NRN;T?6HOGT.D*NM:V-%Y6A-+(V/;6LY>,$] 6$!C?9P9L+/?'^
MW**7W1?;J;K5\QCGN-]C929]<C3VH="0+ J04&BLD+.$";@)7(.'<4U(4*J0
MC:<FV<B***LS+6O5;1IO M>C^G-:,<#XJPN+(]EGJTUJ:TON"QB!#:/6\HF"
M8'G5-[+MP-_8<M:1?$A&JRD8-@A';?!LC^A"A7/UGJL=KC">9^TSC;N(QQI*
M#HL8AC)9"50O]P;@.,I81N<0W;BFGT7$,D> S96^/]9VOFE^^=0N41?)3+/,
MP>?')JV$1[B D1F5ONHK85#C),)2=!GV-[5':"526-_D/^6<:LDI>T* R*;8
MD5&[.=V)EB;)^[+$IF4JT-7EXW](];@Q:LF@-;-G:.&.5F.9MK.S%MJ:"W0
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MR_3CAI^Z:1/S">@@.JVEWDD>R*Q*=;O[2+@WJ6L^KW*/>/?1]C<&%GM!HYP
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M&=3L^36^1I&"D35=4+ Q/TPM39B11PO)ES#8+OF(<-;S;)IC08875G0N@7F
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M"*(<3JPU9!BKF>H(]-:?<1L#FHQ!T"8D^+7IH]7-OKZAWSM1=[#!C/47><@
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MM*09V,?F[]4CYPPQ#MQ8(O9&D0KW#:H6<%48)UA-S:8 FP]<Y:U,"X/$A(>
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MZQ_97N6(?!!,!^__]S$-4P]YD!]*7\:-UPE]E&>@N3&C_]9@$9(7%@4T/]W
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M08H_,#Q^!/J.JBE(E;W;10KL93EV@R%^=LY)A?QF(3F'N&*2W%(=+M5M:-^
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MR$!]_F<4S *0J&>X;)"K0)*-P4:[(EV&<MMYT5"D^*LE<RY9';YW5.6C\Z!
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MS^E)T*J( &Q]A@ P63.$90)\]>J3,@!$E\"$1*SX!'[C"-*KU:H&DEV[MQ\
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MR=ZTS\O-]C4['?RY:-F/9[E#,'0;O0-2J>@:RE\,.\.*HS]>@V:Y5MW_=O;
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M^J-A*A-BL(OE.$RQH+(W-*<%K.*2!']PN.&P(F*H<)HJ 6P\+\(K"@O"#3-
M]T4 D<D";%:D";94'YQ1M"F6;8A4LW]N]!N8+:F &K18.$U[A"<".-").*1=
M88"E 1'/&G0J)&'THPXNQU%B$IP;MFHO[N%0M6R<#M@WLKX=!Z@&5Z::]R<
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MSE2G-ABW7Y%JV]"HF[H^,;PG%-Z^5CS<=(N",:=V@@&\)PN"PAF^E>)BXA.
M[>$&+.B8FJJHMFH,KW'B@%19VXH"%'-BL\!H!QC8+P6!+YG=^LU&P0>=X=>&
MJ5T;04(?B#OE[)"1;75T.QAL.=]SS J>!=@]8= !*^25%0W@J@!')ZN-KGB8
M?'K$^+O!Q!"RV+*L"43O1)2H<9'I7UQGDC+&5:031_R4DA0_!H/H4=@HI>Q
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M,C4P,U]E>#$M,2YH=&U02P$"% ,4    "  3@F53>\)Q(;00  #0.@  $0
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H;"TR,#(Q,3$P-5]P<F4N>&UL4$L%!@     '  < P $  +G#      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
